| A |
| Aarstøy H. |
- |
NT-PROBNP, AND NOT TF, FM, PAPP-A, MPO OR CD40 LIGAND, PREDICTS RECURRENT TROPONIN-T POSITIVE CARDIAC EVENTS FOLLOWING AN ACUTE MYOCARDIAL INFARCTION |
| Aaspollu A. |
- |
PLATELET AGGREGATION INHIBITING COMPONENTS FROM VIPERA LEBETINA SNAKE VENOM |
| Abbadessa V. |
- |
ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS |
| Abbate R. |
- |
QUALITY OF OAT AND VTE RECURRENCE |
| |
- |
VITAMIN B6 AND FOLIC ACID ARE RISK FACTORS FOR RETINAL VEIN OCCLUSION INDEPENDENTLY OF HOMOCYSTEINE LEVELS |
| |
- |
ROLE OF D-DIMER IN COMBINATION WITH F1+2, RVO AND THROMBOPHILIA IN THE RISK OF RECURRENCE OF PATIENTS WITH A FIRST VTE EPISODE AFTER OAT WITHDRAWA |
| |
- |
LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS |
| |
- |
CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY |
| |
- |
CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS BEFORE AND AFTER CARDIAC SURGERY |
| |
- |
EFFECT OF REHABILITATION PROGRAM ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS UNDERGOING CARDIAC SURGERY |
| |
- |
EFFICACY OF OMEGA-3 FATTY ACIDS IN LOWERING LIPOPROTEIN(A) LEVELS |
| |
- |
LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY |
| |
- |
MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME |
| |
- |
ALTERED ULTRALARGE VON WILLEBRAND FACTOR LEVELS AND ADAMTS-13 ACTIVITY AFFECT RESIDUAL PLATELET REACTIVITY IN HIGH RISK VASCULAR PATIENTS ON DUAL ANTIPLATELET THERAPY |
| |
- |
FISH INTAKE AND LPA 93CT POLYMORPHISM: GENE-ENVIRONMENT INTERACTION IN MODULATING LIPOPROTEIN (A) CONCENTRATIONS |
| |
- |
HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION |
| |
- |
PHYSICAL ACTIVITY AND CARDIOVASCULAR RISK FACTORS IN A MIDDLE-AGED URBAN ITALIAN POPULATION |
| |
- |
GENE EXPRESSION PROFILE INDUCED BY PHYSICAL EXERCISE IN RATS |
| |
- |
ASSOCIATION OF THE G681A POLYMORPHISM OF CYP2C19 GENE WITH RESPONSE VARIABILITY TO DUAL ANTIPLATELET TREATMENT IN HIGH RISK VASCULAR DISEASE PATIENTS |
| |
- |
ASSESSMENT OF CLOT LYSIS TIME TISSUE FACTOR-INDUCED BY EXOGENOUS T-PA IN HEALTHY SUBJECTS BY USING A MICROPLATE READER |
| |
- |
ASSOCIATION BETWEEN METHYLENETETRAHYDROFOLATE REDUCTASE AND INFLAMMATORY MARKERS IN THE INCHIANTI STUDY |
| |
- |
HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION |
| |
- |
MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY |
| |
- |
POST-TREATMENT PLATELET FUNCTION PREDICTS MYOCARDIAL INJURY IN ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PCI |
| |
- |
B-GROUP VITAMINS' PROFILE AND OCCURRENCE OF CORONARY ARTERY DISEASE: A CASE-CONTROL STUDY |
| |
- |
PHYSICAL ACTIVITY DURING LEISURE TIME AND PRIMARY PREVENTION OF CORONARY HEART DISEASE: AN UPDATED METAANALYSIS OF COHORT STUDIES |
| |
- |
THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS |
| |
- |
HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES |
| |
- |
HIGH-THROUGHPUT MULTIPLEX SINGLE-NUCLEOTIDE POLYMORPHISM (SNP) ANALYSIS IN GENES INVOLVED IN METHIONINE METABOLISM |
| |
- |
RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE |
| |
- |
PROTEIN Z PLASMA LEVELS IN DIFFERENT LOCALIZATIONS OF ATHEROSCLEROTIC DISEASE |
| Abbate M. |
- |
ROSUVASTATIN EXERTS RENOPROTECTIVE EFFECTS IN STROKE-PRONE RATS BY MODULATING THE PLASMINOGEN/PLASMIN SYSTEM AND THE METALLOPROTEASES EXPRESSION |
| Abbate R. |
- |
GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS |
| |
- |
ABDOMINAL AORTIC ANEURYSM AND CAROTID ARTERY DISEASE: GENE EXPRESSION PROFILING OF TWO ATHEROSCLEROTIC DISEASES |
| |
- |
GENETIC ANALYSIS OF 56 POLYMORPHISMS IN 18 GENES INVOLVED IN HOMOCYSTEINE METABOLISM IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM |
| |
- |
ROLE OF INFLAMMATION IN MODULATING GRAFT TOLERANCE INDUCED BY MESENCHIMAL STEM CELLS |
| |
- |
DO HIGH SENSITIVITY C-REACTIVE PROTEIN AND CYSTATIN-C SERUM LEVELS PREDICT TOTAL MORTALITY IN HEART FAILURE PATIENTS? |
| |
- |
IN PERIODONTAL DISEASE THE INFLAMMATORY STATE IS ASSOCIATED WITH SUB-CLINICAL ATHEROSCLEROSIS |
| |
- |
CHANGES OF INFLAMMATORY MARKERS DURING FOLLOW-UP OF PATIENTS WITH HEART FAILURE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY |
| |
- |
PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS |
| |
- |
THROMBOPHILIA IS FREQUENT IN SUPERFICIAL VEIN THROMBOSIS AND IS ASSOCIATED WITH RECURRENCE |
| |
- |
HOMOCYSTEINE AS INDICATOR OF OSTEOPOROSIS. THE INCHIANTI STUDY |
| |
- |
LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS |
| Abbene I. |
- |
PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY |
| |
- |
THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE |
| |
- |
ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS |
| Abd El-Kader A. |
- |
PROGNOSTIC SIGNIFICANCE OF MRD (MINIMAL RESIDUAL DISEASE) QUANTIFICATION BY PCR IN CHILDHOOD ACUTE LEUKEMIA |
| Abdel Gadir A.M. |
- |
HAEMOSTATIC AND CYTOKINE CHANGES IN GESTATIONAL AND PREGESTATIONAL DIABETES MELLITUS |
| Abdelnoor M. |
- |
PLASMINOGEN ACTIVATOR INHIBITOR-1 ACTIVITY PREDICTS RHYTHM OUTCOME AFTER ELECTRICAL CARDIOVERSION FOR ATRIAL FIBRILLATION |
| Abdelrahim M. |
- |
IMPACT OF TISSUE FACTOR-BEARING MICROPARTICLES DERIVED FROM TUMOR CELLS ON COAGULATION ACTIVATION |
| Abdihakim A. |
- |
HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION |
| Abdollahi M. |
- |
THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS |
| Abdullahi A. |
- |
THROMBOPHILIA IS FREQUENT IN SUPERFICIAL VEIN THROMBOSIS AND IS ASSOCIATED WITH RECURRENCE |
| Abdullahi Said A. |
- |
CHANGES OF INFLAMMATORY MARKERS DURING FOLLOW-UP OF PATIENTS WITH HEART FAILURE UNDERGOING CARDIAC RESYNCHRONIZATION THERAPY |
| |
- |
RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE |
| |
- |
THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS |
| Abe Y. |
- |
ADAMTS13 RELATED MARKERS IN PLASMA FROM PATIENTS WITH TTP |
| |
- |
PHARMACOLOGICAL CHARACTERIZATION OF AN ORAL DIRECT THROMBIN INHIBITOR, MCC-977: HIGH THROMBIN SPECIFICITY AND LOW HEMORRHAGIC PROFILE |
| Abe K. |
- |
PLATELET VOLUME IN CORD BLOOD |
| Abe Y. |
- |
ELEVATED D-DIMER LEVELS IN PATIENTS WITH DEEP VEIN THROMBOSIS |
| Abedini M. |
- |
EVALUATION FOR HYPERCOAGULOPATHY IN THALASSEMIA MAJOR PATIENTS IN ISFAHAN |
| Åberg M. |
- |
ANTIAPOPTOTIC SIGNALING BY TF/FVIIA IS INHIBITED BY SIMVASTATIN |
| Abgrall J. |
- |
DETECTING PROTHROMBOTIC STATES USING A THROMBIN GENERATION TEST IN RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND FACTOR V LEIDEN |
| Abid-Hussein M.N. |
- |
INHIBITION OF MICROPARTICLE RELEASE TRIGGERS ENDOTHELIAL APOPTOSIS |
| |
- |
SIMVASTATIN-INDUCED ENDOTHELIAL CELL DETACHMENT AND MICROPARTICLE RELEASE ARE PRENYLATION DEPENDENT |
| Abinet I. |
- |
PROPOSITION FOR A MULTI-STEP MUTATION DETECTION IN HAEMOPHILIA A |
| Abo A. |
- |
RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SYNERGIZES WITH 5-FU OR BEVACIZUMAB IN A MOUSE MODEL OF COLORECTAL CANCER |
| |
- |
RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SUPPRESSES LIVER AND LUNG METASTASES IN MOUSE MODELS OF COLORECTAL CANCER |
| Aboud M. |
- |
A COMPARATIVE STUDY OF LOW MOLECULAR WEIGHT HEPARIN (LMWH) MONITORING BY ANTI-XA LEVELS, OVERALL HAEMOSTASIS POTENTIAL (OHP) AND CALIBRATED AUTOMATED THROMBOGRAM (CAT) ASSAYS |
| |
- |
FIBRIN GENERATION IS NOT SUPPRESSED IN PATIENTS WARFARINISED FOR VENOUS THROMBOEMBOLISM (VTE) |
| Aboulfatova K. |
- |
HUMAN VH1-69 GERMLINE GENE ENCODED ANTI-SPACER DOMAIN ANTIBODIES THAT DEVELOP IN PATIENTS WITH ACQUIRED TTP INTERFERE WITH THE BINDING OF ADAMTS13 TO VWF |
| Aboulghar M. |
- |
THROMBOPHILIA & RECURRENT FETAL LOSS: SHOULD WE SCREEN BOTH PARENTS ? |
| Abrahams J.M. |
- |
NEOINTIMAL CELLS IN WIRE-INJURED ARTERIES HAVE A MIXED ENDOTHELIAL CELL (EC)/VASCULAR SMOOTH MUSCLE CELL (VSMC) PHENOTYPE WHICH IS THROMBIN-DEPENDENT |
| |
- |
NK CELL AND MACROPHAGE INFILTRATION INTO ORGAN XENOGRAFTS IS DEPENDENT ON THROMBIN-MEDIATED PRODUCTION OF MONOCYTE CHEMOTACTIC PROTEIN-1(MCP-1) THROUGH PAR-1 |
| |
- |
THROMBIN PROMOTES ANOMALOUS DIFFERENTIATION OF VASCULAR PROGENITOR CELLS DURING NEOINTIMAL HYPERPLASIA AFTER WIRE-INDUCED INJURY |
| Abreu Lima J. |
- |
SCREENING FOR THROMBOPHILIA: RETROSPECTIVE STUDY IN WOMEN WITH GESTACIONAL VASCULAR COMPLICATIONS |
| Abshire T.C. |
- |
U.S. INHIBITOR PILOT PROJECT: STUDY DESIGN AND METHODS VALIDATION |
| Abu-Ghoush M.W.H. |
- |
INHERITED BLEEDING DISORDERS- A 14 YEAR RETROSPECTIVE STUDY |
| Achard V. |
- |
DISRUPTION OF PAI-1 CIRCADIAN RHYTHM IN OBESE SUBJECTS MAY EXPLAIN A CHANGE IN THE TIME OF ONSET OF MYOCARDIAL INFARCTION |
| Achtergael W. |
- |
DIAGNOSTIC ACCURACY OF THE TRIAGE D-DIMER TEST FOR EXCLUSION OF VENOUS THROMBOEMBOLISM IN OUTPATIENTS |
| Ackerman P. |
- |
GENERIC VERSIONS OF BRANDED LOW MOLECULAR WEIGHT HEPARINS CAN BE DIFFERENTIATED IN BIOLOGIC AND PHARMACOLOGIC ASSAYS |
| Adam M. |
- |
ANTITHROMBIN (AT) COMPLEX FORMATION IN BEAGLE DOGS AFTER ADMINISTRATION OF A PHARMACOLOGICAL DOSE OF HUMAN RECOMBINANT FACTOR VIIA (RFVIIA) |
| Adam F. |
- |
PAR4 INDUCES FULL PLATELET SPREADING ON A FIBRINOGEN MATRIX: INVOLVEMENT OF ERK2 AND P38 AND CA2+ MOBILIZATION |
| |
- |
INVOLVEMENT OF THE MAP KINASE JNK1 IN THROMBUS FORMATION |
| Adam M. |
- |
DECREASE FACTOR VIIA/ANTITHROMBIN COMPLEXES IN PATIENTS WITH VENOUS THROMBOEMBOLISM: A NEW INSIGHT IN THE PATHOGENETIC MECHANISM |
| Adam Z. |
- |
LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY |
| Adam M. |
- |
ASSAY DEVELOPMENT FOR PLASMA FACTOR VIIA-ANTITHROMBIN COMPLEX (FVIIA-AT) |
| |
- |
COMPARISON OF A HEPARIN-PLATELET FACTOR 4 (PF4)-ELISA FOR IGG, IGM AND IGA AND THE HEPARIN-INDUCED PLATELET ACTIVATION ASSAY (HIPA) WITH A HEPARIN-PF4-ELISA FOR IGG |
| Adamczuk Y.P. |
- |
CORRELATION BETWEEN DIFFERENT FIBRINOLYTIC TESTS IN PATIENTS WITH OBSTETRIC COMPLICATIONS |
| Adamczuk Y. |
- |
THROMBOPHILIA IN HIV-INFECTED PATIENTS WITH OSTEONECROSIS: IS THERE A REAL CONNECTION? THE FIRST CASE-CONTROL STUDY |
| Adamopoulos A. |
- |
DOES ADMINISTRATION OF LANSOPRAZOLE AFFECT ASA ANTIPLATELET FUNCTION IN HIGH RISK CARDIOVASCULAR PATIENTS? PRELIMINARY RESULTS |
| Adams B. |
- |
DETERMINATION OF THE OESTROGEN RESPONSIVENESS OF A POLYMORPHIC ELEMENT IN THE HUMAN FACTOR IX GENE PROMOTER |
| Adams J. |
- |
CERTIFY, A PHASE III STUDY COMPARING CERTOPARIN WITH UNFRACTIONATED HEPARIN IN ELDERLY, ACUTELY ILL MEDICAL PATIENTS |
| Adams M. |
- |
THE SAFETY OF ANTICOAGULANTS IN PEDIATRIC ARTERIAL ISCHEMIC STROKE: PRELIMINARY RESULTS |
| Adamson U. |
- |
FIBRIN GEL POROSITY RELATES TO GLYCOSYLATED HAEMOGLOBIN IN PATIENTS WITH TYPE 1 DIABETES |
| |
- |
FIBRIN GEL POROSITY: COMPARISON OF TWO LABORATORY ASSAYS |
| Adamson P.J. |
- |
THE LOCALISATION OF A NOVEL FACTOR XIIIB BINDING SITE ON THE ALPHA CHAIN OF FIBRINOGEN AND ITS ROLE IN FXIII DISSOCIATION |
| |
- |
IDENTIFICATION OF PROTEOLYTIC CLEAVAGE |
| |
- |
MULTIPLE SITES OF FXIIIA ARE INVOLVED IN THE BINDING INTERACTION TO THE ALPHA CHAIN OF FIBRINOGEN |
| |
- |
PROTEOLYTIC CLEAVAGE OF ACTIVATED COAGULATION FACTOR XIII BY PLASMIN: NOVEL MECHANISM OF FACTOR XIII REGULATION? |
| Ádány R. |
- |
MODULATION OF THE RISK OF CORONARY ARTERY DISEASE BY THE INTERACTION BETWEEN FACTOR XIII SUBUNIT A VAL34LEU POLYMORPHISM AND FIBRINOGEN CONCENTRATION IN THE HUNGARIAN POPULATION |
| |
- |
FACTOR XIII VAL34LEU VARIANT PROTECTS AGAINST CORONARY ARTERY DISEASE: A META-ANALYSIS |
| Adelmeijer J. |
- |
GLYCOPROTEIN IB-ALPHA CONTRIBUTES TO TISSUE FACTOR-INDEPENDENT THROMBIN GENERATION BY RECOMBINANT FACTOR VIIA ON THE ACTIVATED PLATELET SURFACE |
| Adida K. |
- |
IMPACT OF RISK FACTORS ASSOCIATED WITH VENOUS THROMBOSIS IN CYPROTERONE ACETATE AND ETHYNIL-ESTRADIOL USERS OR OTHER ORAL CONTRACEPTIVES USERS AND POSSIBLY PREVENTABLE CASES |
| Adinolfi E. |
- |
RELEASE OF TISSUE FACTOR-BEARING MICROPARTICLES BY HUMAN DENDRITIC CELLS INDUCED BY STIMULATION OF MEMBRANE P2X7 RECEPTORS |
| Aditya M. |
- |
NONINVASIVELY MEASURED AORTIC PULSE WAVE VELOCITY FOR DETECTION OF OBSTRUCTIVE CORONARY ARTERY DISEASE |
| Adler G. |
- |
THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 REDUCES THROMBUS FORMATION IN A RAT MODEL |
| Adraktas T. |
- |
SAFETY AND EFFICACY OF TINZAPARIN ADMINISTRATION DURING PREGNANCY |
| Afrabiasi A. |
- |
GENETIC CHARACTERIZATION OF PATIENTS WITH BERNARD-SOULIER SYNDROME AND THEIR RELATIVES FROM SOUTHERN IRAN |
| Afrasiabi A. |
- |
PHENOTYPIC ANALYSIS OF THREE MUTATIONS CAUSING GLANZMANN THROMBASTHENIA |
| |
- |
KINETICS STUDIES OF A NATURALLY OCCURRING MUTATION ON FACTOR X (FX) GENE (G222D) |
| |
- |
DETERMINATION OF PROTEIN C LEVEL IN NEONATES WITH SEPSIS LIKE ILLNESS |
| |
- |
FACTOR XI DEFICIENCY IN SOUTHERN IRAN AND REVIEW OF LITERATURE |
| |
- |
PLATELET ADAMTS13 AND IN VITRO EXPRESSION STUDY OF A PATIENT AFFECTED BY CONGENITAL TTP |
| Afrasiabi R. |
- |
INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS |
| Afshar H. |
- |
TIME COURSE OF COAGULATION FACTORS IN OVERT DISSEMINATED INTRAVASCULAR COAGULATION: A CASE STUDY |
| Aganezova N.V. |
- |
PREVALENCE OF HYPERHOMOCYSTEINEMIA IN WOMEN WITH PREMENSTRUAL SYNDROME AND EFFECT OF ORAL AND VAGINAL DELIVERY OF ETHINYL ESTRADIOL AND DEZOGESTREL ON HOMOCYSTEINE LEVELS |
| Ageenkova E.V. |
- |
LEVEL OF PLASMA GLYCOCALICIN IN CHILDREN WITH THROMBOCYTOPENIA |
| |
- |
MASSIVE BLEEDINGS IN GIRLS DURING AND AFTER TERATOMAS EXCISION |
| |
- |
IDIOPATHIC THROMBOCYTOPENIC PURPURA AND OPPORTUNISTIC INFECTIONS IN CHILDREN |
| Agenent W. |
- |
ANALYSING PLATELET FUNCTION FOR FUNCTIONAL GENOMIC STUDIES |
| Ageno W. |
- |
A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS |
| |
- |
CARDIOVASCULAR RISK FACTORS AND VENOUS THROMBOEMBOLISM: A META-ANALYSIS |
| |
- |
PREVALENCE OF UNPROVOKED VENOUS THROMBOEMBOLISM AND OF TRANSIENT AND PERMANENT RISK FACTORS IN DIFFERENT AGE GROUPS: RESULTS OF THE MASTER REGISTRY |
| |
- |
METABOLIC SYNDROME AND HYPERHOMOCYSTEINEMIA IN PATIENTS WITH DEEP VEIN THROMBOSIS: A CASE-CONTROL STUDY |
| |
- |
ISOLATED DISTAL DEEP VEIN THROMBOSIS (ID-DVT) IN THE MASTER MULTICENTER ITALIAN REGISTRY |
| |
- |
SUBCLINICAL HYPOTHYROIDISM AND DEEP VENOUS THROMBOSIS. A PILOT CROSS-SECTIONAL STUDY |
| |
- |
EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES |
| |
- |
INDIVIDUAL AND CLINICAL PREDICTORS OF THE TIMING OF DIAGNOSIS OF VENOUS THROMBOEMBOLISM: RESULTS FROM THE MASTER REGISTRY |
| |
- |
SPIRAL COMPUTED TOMOGRAPHY IN THE EVALUATION OF THE RESOLUTION OF PULMONARY EMBOLISM AFTER A STANDARD COURSE OF ANTICOAGULATION |
| |
- |
LATE BREAKING CLINICAL TRIAL: RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL KNEE REPLACEMENT SURGERY: RESULTS OF THE RECORD 3 STUDY - LATE BREAKING |
| |
- |
EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY |
| |
- |
PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY |
| |
- |
INHERITED THROMBOPHILIC ABNORMALITIES AND RISK OF PORTAL VEIN THROMBOSIS: A META-ANALYSIS |
| |
- |
DELAY IN STARTING ORAL ANTICOAGULATION IN PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM (VTE): ANALYSIS FROM THE MASTER REGISTRY |
| |
- |
CLINICAL CHARACTERISTICS OF CANCER ASSOCIATED ACUTE VENOUS THROMBOEMBOLISM: FINDINGS FROM THE MASTER REGISTRY |
| |
- |
SHOULD COMMON INERITED THROMBOPHILIC ABNORMALITIES BE TESTED IN CANCER PATIENT WITH CENTRAL VENOUS CATHETER? |
| |
- |
HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM |
| |
- |
BRAIN NATRIURETIC PEPTIDE AS A PRECLINICAL MARKER OF CHRONIC PULMONARY HYPERTENSION IN PATIENTS WITH PULMONARY EMBOLISM |
| Agerkvist I. |
- |
A NOVEL RECOMBINANT B-DOMAIN-DELETED FACTOR VIII EXPRESSED IN A HUMAN CELL LINE |
| Aggio M. |
- |
THROMBOPHILIA AND ISCHEMIC STROKE: A RETROSPECTIVE STUDY |
| Aghighi S. |
- |
THROMBIN GENERATION TEST (TGT) AND ROTATIONAL THROMBOELASTOGRAPHY (ROTEM) AND ITS USE IN ASSESSING SEVERE HAEMOPHILIA A PHENOTYPE |
| Aghili M. |
- |
THE CLINICAL RESULTS OF P32 RADIOSYNOVECTOMY IN HEMOPHILIC PATIENTS WITH CHRONIC SYNOVITIS |
| Agnelli G. |
- |
PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY |
| |
- |
EFFECT OF BLOOD SALVAGE AND RE-INFUSION ON VTE COMPLICATIONS IN PATIENTS UNDERGOING ELECTIVE MAJOR ORTHOPEDIC SURGERY |
| |
- |
INDIVIDUAL AND CLINICAL PREDICTORS OF THE TIMING OF DIAGNOSIS OF VENOUS THROMBOEMBOLISM: RESULTS FROM THE MASTER REGISTRY |
| |
- |
LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS |
| |
- |
EDHIT: EVALUATION OF DERMATAN SULPHATE IN PREVENTION AND TREATMENT OF HEPARIN INDUCED THROMBOCYTOPENIA |
| |
- |
ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN HEMOPHILIA PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS |
| |
- |
OPTIMAL DURATION OF ANTICOAGULANT TREATMENT IN PATIENTS WITH VENOUS THROMBOEMBOLISM |
| |
- |
PHARMACOKINETICS OF THE REFORMULATED B-DOMAIN DELETED RECOMBINANT FACTOR VIII (BDD-RFVIII) CONCENTRATE USING CHROMOGENIC AND ONE-STAGE ASSAYS WITH POOLED NORMAL PLASMA (PNP) AND REFACTO LABORATORY STANDARD (RLS) |
| |
- |
HELICAL COMPUTED TOMOGRAPHY TO ASSESS RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH ACUTE PULMONARY EMBOLISM |
| |
- |
CLINICAL CHARACTERISTICS OF CANCER ASSOCIATED ACUTE VENOUS THROMBOEMBOLISM: FINDINGS FROM THE MASTER REGISTRY |
| |
- |
PROGNOSTIC VALUE OF TROPONINS IN ACUTE PULMONARY EMBOLISM: A META-ANALYSIS |
| |
- |
DELAY IN STARTING ORAL ANTICOAGULATION IN PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM (VTE): ANALYSIS FROM THE MASTER REGISTRY |
| |
- |
HAEMOPHILIA MANAGEMENT THROUGH AN INTER-REGIONAL NETWORK IN MIDDLE ITALY |
| |
- |
ISOLATED DISTAL DEEP VEIN THROMBOSIS (ID-DVT) IN THE MASTER MULTICENTER ITALIAN REGISTRY |
| |
- |
RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS |
| |
- |
PREVALENCE OF UNPROVOKED VENOUS THROMBOEMBOLISM AND OF TRANSIENT AND PERMANENT RISK FACTORS IN DIFFERENT AGE GROUPS: RESULTS OF THE MASTER REGISTRY |
| |
- |
TREATMENT OF PROXIMAL DEEP VEIN THROMBOSIS (DVT): RIVAROXABAN ONCE OR TWICE DAILY HAD SIMILAR EFFICACY AND SAFETY TO STANDARD THERAPY IN PHASE II STUDIES |
| |
- |
A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS |
| |
- |
EFFECT OF BOLUS TENECTEPLASE (TNK) ON RIGHT VENTRICULAR DYSFUNCTION IN NORMOTENSIVE PATIENTS WITH PULMONARY EMBOLISM: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY |
| |
- |
SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION |
| Agniullin J.V. |
- |
SUPERFICIAL THROMBOSIS (RATS AND RABBITS) AND ITS TREATMENT WITH THROMBOLYTIC PREPARATION LONGOLYTIN |
| |
- |
EXPERIMENTAL MODEL OF THROMBOSIS IN RABBIT'S MARGINAL EAR VEIN |
| Ågren A. |
- |
LABORATORY EVIDENCE OF HYPERFIBRINOLYSIS IN ASSOCIATION WITH LOW PAI-1 ACTIVITY |
| Aguado E. |
- |
ROLES OF THE C-TERMINAL TYROSINE RESIDUES OF LAT IN GPVI-INDUCED PLATELET ACTIVATION; INSIGHT INTO THE MECHANISM OF PLC GAMMA2 ACTIVATION |
| Aguiar A. |
- |
USE OF RFVIIA IN ELECTIVE SURGERY IN CASES WITH CONGENITAL COAGULOPATHIES AND INHIBITORS |
| Aguilar G. |
- |
RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SUPPRESSES LIVER AND LUNG METASTASES IN MOUSE MODELS OF COLORECTAL CANCER |
| |
- |
RNAPC2, A NOVEL INHIBITOR OF TISSUE FACTOR/FACTOR VIIA COMPLEX, SYNERGIZES WITH 5-FU OR BEVACIZUMAB IN A MOUSE MODEL OF COLORECTAL CANCER |
| Aguilar C. |
- |
CLINICAL EVALUATION OF A NEW QUANTITATIVE HIGHLY SENSITIVE D-DIMER ASSAY FOR EXCLUSION OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM |
| Agustsdottir M. |
- |
PREDICTION OF PRIMARY HEMOSTATIC DEFECT TYPE AND SEVERITY WITH THE PFA-100 CLOSURE TIME |
| Aguzzi G. |
- |
SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION |
| Ahamed J. |
- |
THE TISSUE FACTOR CYTOPLASMIC DOMAIN REGULATES PROCOAGULANT RESPONSES IN MACROPHAGES |
| Aharon A. |
- |
MICROPARTICLES' INDUCE PRO-COAGULANT AND APOPTOTIC EFFECTS ON ENDOTHELIAL CELLS |
| |
- |
THE ROLE OF MICROPARTICLES IN GESTATIONAL VASCULAR COMPLICATIONS |
| Ahl S. |
- |
MONOCLONAL ANTIBODIES THAT MIMIC ANTIBODIES FOUND IN PATIENTS WITH DRUG (QUININE(QN))-INDUCED IMMUNE THROMBOCYTOPENIA (DITP): IMPLICATIONS FOR THE PATHOGENESIS OF DITP |
| Ahluwalia J. |
- |
INVESTIGATION OF THROMBOPHILIA DURING PREGNANCY AND PUERPERIUM: A STUDY FROM NORTH INDIA |
| Ahmad S. |
- |
MODULATION OF HEPARIN-PF4 ANTIBODY-MEDIATED PLATELET ACTIVATION BY A NOVEL GPIIB/IIIA RECEPTOR ANTAGONIST: IMPLICATIONS IN THE MANAGEMENT OF HIT |
| Ahmad R.U. |
- |
PHARMACOKINETICS (PK) OF RVWF IN DOGS AND MICE WITH SEVERE VWD |
| Ahmadinejad M. |
- |
HIGH PREVALENCE OF ELEVATED FACTOR VIII IN IRANIAN PATIENT WITH IDIOPATHIC VENOUS THROMBOEMBOLISM |
| |
- |
HEREDITARY THROMBOPHILIC DEFECTS IN IRANIAN PATIENTS WITH CEREBRO VASCULAR ACCIDENT |
| |
- |
HEREDITARY DEFICIENCIES OF ANTITHROMBIN, PROTEIN S, AND THE PROTEIN C PATHWAY IN IRANIAN DVT PATIENTS |
| Ahmady Negad M. |
- |
THROMBOTIC EVENTS IN PATIENTS WITH ELEVATED FVIII LEVEL |
| Ahnadi C.E. |
- |
EVALUATION OF THE ANTICOAGULANTS EDTA CONTAINING DISODIUM DIAZOLIDYL UREA TO PREVENT UNSOLICITED PLATELET ACTIVATION |
| Ahrens I. |
- |
MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS |
| |
- |
EVIDENCE FOR AN ALTERNATIVE REGULATION OF THE ACTIVITY OF THE BETA3-INTEGRIN ALPHAVBETA3 IN THE ABSENCE OF THE HIGHLY CONSERVED ALPHA-SUBUNIT GFFKR MOTIF |
| Aiach M. |
- |
BONE MARROW-DERIVED MONONUCLEAR CELL THERAPY INDUCES DISTAL ANGIOGENESIS AFTER LOCAL INJECTION IN CRITICAL LEG ISCHEMIA |
| |
- |
EVIDENCE OF PROTEIN C (PC) GLA DOMAIN AMINO ACIDS CRUCIAL FOR INTERACTION WITH PROTEIN S (PS) |
| |
- |
AN ABNORMAL MRNA SPLICING IS ASSOCIATED WITH THE A3 HAPLOTYPE OF THE EPCR GENE PROCR: A POSSIBLE NEW CONTRIBUTOR TO PLASMA SOLUBLE EPCR LEVELS |
| |
- |
RECOMBINATION IN ENDOTHELIAL CELL PROTEIN C RECEPTOR GENE PROCR. INFERENCE FOR THROMBOPHILIC PATIENTS SCREENING |
| |
- |
THROMBIN ADSORBED TO A FIBRIN CLOT CONFERS ANGIOGENIC AND HEMOSTATIC PROPERTIES ON ENDOTHELIAL PROGENITOR CELLS |
| |
- |
THE ABCB1 (MDR1) C3435T POLYMORPHISM DOES NOT INFLUENCE PHARMACODYNAMIC RESPONSE TO CLOPIDOGREL IN HEALTHY SUBJECTS |
| |
- |
COMPARISON OF ENDOTHELIAL CELL PROTEIN C RECEPTOR (EPCR) MRNA FORMS IN MONOCYTES AND HUVEC |
| |
- |
THE RGDS SEQUENCE OF THE ANTICOAGULANT PROTEIN C (PC) CONTRIBUTES TO ITS ENDOTHELIAL CELL RECEPTOR (EPCR) BINDING |
| |
- |
ALL PROTEIN S (PS) EPIDERMAL GROWTH FACTOR LIKE DOMAINS (EGFS) SIGNIFICANTLY PARTICIPATE TO ACTIVATED PROTEIN C (APC) COFACTOR ACTIVITY |
| Aillaud M. |
- |
CYP 2C19*2 AND MDR1+3435C ALLELES CONTRIBUTE TO LOW RESPONSE TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME |
| Aillaud M.F. |
- |
RISK OF A FIRST VENOUS OR ARTERIAL EVENT IN CARRIERS OF A FAMILIAL THROMBOPHILIC DEFECT |
| Aird W. |
- |
VASCULAR BED-SPECIFIC THROMBOSIS |
| Aisina R.B. |
- |
FIBRINOLYTIC SYSTEM COMPONENTS IN RABBIT TEARS AFTER CHEMICAL BURN OF CORNEA |
| |
- |
MODULATION OF STAPHYLOKINASE-DEPENDENT PLASMINOGEN ACTIVATION BY OMEGA-AMINE ACIDS |
| |
- |
INHIBITION OF PLASMINOGEN/PLASMINOGEN ACTIVATOR SYSTEM BY ANGIOSTATIN-LIKE PLASMINOGEN FRAGMENTS IS INVOLVED IN MECHANISM OF ANTIANGIOGENESIS |
| Aït Chafa-Tadlaoui D. |
- |
HEMOSTASIS AND PREGNANCY: PRELIMINARY STUDY |
| |
- |
NORMAL VALUES IN PERINATAL AND PEDIATRIC HEMOSTASIS IN ALGIERS |
| Aizawa Y. |
- |
PREVALENCE OF DEEP VENOUS THROMBOSIS IN A YEAR AFTER THE MID NIIGATA PREFECTURE EARTHQUAKE |
| |
- |
CHARACTERISTIC FEATURES OF SOLUBLE FIBRIN (SF) AND SOLUBLE FIBRIN MONOMER COMPLEX (FMC) AS MEASURED BY IMMUNOASSAYS WITH IATRO SF AND AUTO LIAFM, RESPECTIVELY |
| Ajjan R. |
- |
RECOMBINANT BBETA-LYS448 IS ASSOCIATED WITH SIGNIFICANT CHANGES IN FIBRIN STRUCTURE AND CLOT RIGIDITY |
| Ajzenberg N. |
- |
SCREENING FOR THROMBOPHILIA IN A RETROSPECTIVE STUDY OF 320 WOMEN WITH PREGNANCY COMPLICATIONS |
| |
- |
A ROLE FOR PLATELET ACTIVATION IN LACUNAR STROKE? |
| |
- |
MONOCYTES DOWN-REGULATE INITIAL PHASE OF COLLAGEN-INDUCED PLATELET ACTIVATION |
| |
- |
INVOLVEMENT OF THE MAP KINASE JNK1 IN THROMBUS FORMATION |
| Ajzner E. |
- |
GENERATION AND EXPRESSION OF RECOMBINANT FACTOR XIII-B MUTANTS |
| Akahane K. |
- |
EXTRACTS OF AN EDIBLE MUSHROOM WITH ANTITHROMBIN III-INDEPENDENT ANTICOAGULANT ACTIVITY |
| Akar N. |
- |
SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR AND CYTOKINE LEVELS IN TURKISH PEDIATRIC STROKE PATIENTS |
| Akarsu S. |
- |
INTRACRANIAL THROMBOSIS COMPLICATING THE MANAGEMENT OF HEMOPHILIC ARTHROPATHY: ANTICOAGULANT TREATMENT IN A CASE WITH HEMOPHILIA B |
| |
- |
USAGE OF FACTOR VIIA IN A CASE OF HEMORRHAGIC CYSTITIS DEVELOPED SECONDARY TO CHEMOTHERAPY |
| Akbalik M. |
- |
CEREBRAL THROMBOSIS ASSOCIATED WITH HETEROZYGOUS FV LEIDEN MUTATION AND HIGH LIPOPROTEIN A LEVEL IN A GIRL WITH FACTOR XIII DEFICIENCY |
| Akbari A. |
- |
FACTOR XI DEFICIENCY IN SOUTHERN IRAN AND REVIEW OF LITERATURE |
| Akhavan S. |
- |
A 2 ADENINE INSERTION POLYMORPHISM IN THE FVII GENE 3'UTR IS ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE BUT NOT WITH VENOUS THROMBOSIS: RESULTS OF CASE-CONTROL STUDIES |
| Akhvlediani M. |
- |
CORRELATION OF HDL CHOLESTEROL WITH SOME LABORATORY PARAMETERS AND CAROTID ARTERIES ATHEROSCLEROTIC LESIONS IN PATIENTS WITH HEART ISCHEMIC DESEASES |
| Akhvlediani M.M.A. |
- |
APPLICATION OF LOW MOLECULAR-WEIGHT HEPARIN (NARDROPARINE) IN PATIENTS WITH LUNG CANCER |
| Akici F. |
- |
EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA |
| |
- |
FX DEFICIENCY: CHARACTERISTICS AND TREATMENT OUTCOME OF SEVEN CASES |
| |
- |
THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS |
| |
- |
RADIOSYNOVECTOMY WITH YTRIUM-90 AND RHENIUM-186 IN HEMOPHILIC ARTHROPATY |
| Akinshina S.V. |
- |
PROPHYLAXIS OF RECURENT PREECLAMPSIA IN PATIENTS WITH THROMBOPHILIA |
| |
- |
PROPHYLAXIS OF THROMBOEMBOLIC COMPLICATIONS IN PREGNANT WOMEN WITH THROMBOPHILIA |
| |
- |
ANTIPHOSPHOLIPID ANTIBODIES SPECTRUM IN WOMEN WITH RECCURENT FETAL LOSS SYNDROME |
| |
- |
PATHOGENETIC PROPHYLAXIS OF RECCURENT FETAL LOSS SYNDROME IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND GENETIC THROMBOPHILIA |
| Akita N. |
- |
REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR |
| Akiyama M. |
- |
SEMAPHORIN 3A ANTAGONIZES AGONIST-INDUCED PI3 KINASE PATHWAY IN PLATELETS |
| Akkerman J. |
- |
A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP |
| Akkerman J.N. |
- |
ACTIVATION OF HUMAN PLATELETS BY MISFOLDED PROTEINS |
| Akkerman J.W.N. |
- |
ROLE OF GLYCOPROTEIN IBA MOBILITY IN PLATELET DESTRUCTION AND FUNCTION |
| Akkerman J.N. |
- |
EFFECT OF SR-BI DEFICIENCY ON PLATELET AGGREGATION AND SUSCEPTIBILITY TO THROMBOSIS |
| |
- |
LDL-INDUCED PLATELET ACTIVATION INVOLVES SPECIFIC DOMAINS IN APOB100 |
| Akkerman J. |
- |
INSULIN INHIBITS TISSUE FACTOR EXPRESSION IN MONOCYTES |
| Akram A. |
- |
HEMOSTASIS IN FACTOR VIII DEFICIENT MICE IS IMPROVED AFTER THE INFUSION OF MONOCYTE-DERIVED MICROPARTICLES |
| Aksu I. |
- |
THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS |
| Aktay Ayaz N. |
- |
FX DEFICIENCY: CHARACTERISTICS AND TREATMENT OUTCOME OF SEVEN CASES |
| |
- |
EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA |
| |
- |
THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS |
| Akulich N.V. |
- |
IMAGE ANALYSIS OF LYMPHOCYTES CHROMATIN AT THE APOPTOSIS |
| Al Dieri R. |
- |
THE NECESSITY OF CONTINUOUS INDIVIDUAL CALIBRATION IN CONTINUOUS FLUOROGENIC MEASUREMENT OF THE THROMBIN GENERATION CURVE |
| Al Muslahi M. |
- |
EVALUATION OF A PRE-TEST CLINICAL SCORE FOR THE DIAGNOSIS OF HIT |
| Ala F.A. |
- |
A NOVEL CANDIDATE A/T789P MUTATION IDENTIFIED IN FIVE PATIENTS WITH TYPE 2N VON WILLEBRAND DISEASE FROM TWO DIFFERENT FAMILIES |
| Ala F. |
- |
EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS |
| Ala F.A. |
- |
GENETIC ANALYSIS OF BERNARD SOULIER PATIENTS IN IRAN: REPORT OF FIVE NOVEL MUTATIONS |
| |
- |
GENETIC ANALYSIS OF PATIENTS WITH FACTOR XIII DEFICIENCY IN IRAN: REPORT OF FOUR NOVEL MUTATIONS |
| Ala F. |
- |
EPIDEMIOLOGY OF BERNARD SOULIER DISEASE |
| |
- |
FACTOR VII GENOTYPE AND CLINICAL PROFILE IN 6 IRANIAN PATIENTS WITH CONGENITAL FACTOR VII DEFICIENCY |
| |
- |
THROMBOSIS IN BETA THALASSEMIA MAJOR |
| |
- |
VON WILLEBRAND DISEASE TYPES 2A MUTATION (C.4789CT, P.R1597W) IN THREE IRANIAN PATIENTS |
| |
- |
FACTOR XI DEFICIENCY: THREE NOVEL MUTATIONS IN IRANIAN PATIENTS |
| Ala F.A. |
- |
THE RISK OF INHIBITOR DEVELOPMENT IN 1104 PATIENTS WITH HEMOPHILIA A ACCORDING TO FACTOR VIII GENOTYPE |
| Alabieva E.A. |
- |
PREVALENCE OF THROMBOPHILIA IN WOMEN WITH PREGNANCY LOSS AND GESTATIONAL OUTCOME IN WOMEN WITH DIAGNOSED THROMBOPHILIA FOLLOWING ANTITHROMBOTIC THERAPY |
| Alacacioglu I. |
- |
THE EFFECT OF EXERCISE ON FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEALTHY VOLUNTEERS |
| Alahmad A. |
- |
RETRIEVABLE INFERIOR VENA CAVA (IVC) FILTERS IN A TERTIARY CARE POPULATION |
| Alamanni C. |
- |
CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS BEFORE AND AFTER CARDIAC SURGERY |
| Alamartine E. |
- |
RENAL IMPAIRMENT ESTIMATES TO PREDICT THE HAEMORRHAGE RISK IN 2170 PATIENTS TREATED BY HEPARIN. COCKCROFT-GAULT OR SIMPLIFIED MDRD? |
| Alatri A. |
- |
LOW MOLECULAR WEIGHT HEPARIN (LMWH) BRIDGING THERAPY DURING SUBTHERAPEUTIC INR LEVELS IN VTE HIGH RISK PATIENTS |
| |
- |
ACCURACY AND COST EVALUATION OF A PORTABLE INR MONITOR |
| |
- |
PROTHROMBIN TIME: COMPARISON BETWEEN DIFFERENT REAGENTS |
| |
- |
EVALUATION OF A NEW D-DIMER METHOD |
| |
- |
PT INR: COMPARISON BETWEEN TWO DIFFERENT POINT OF CARE SYSTEMS |
| |
- |
EVALUATION OF A NEW INR PORTABLE MONITOR |
| Alavi S. |
- |
CHILDHOOD GERM CELL TUMOR PRECEDING BY CHRONIC LONGSTANDING DIC |
| Alavitoosi J. |
- |
EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS |
| |
- |
EPIDEMIOLOGY OF BERNARD SOULIER DISEASE |
| Albalushi T.M. |
- |
CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN |
| |
- |
CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN |
| Alban S. |
- |
INTERACTIONS WITH P-SELECTIN AND ANTIMETASTATIC ACTIVITIES OF NADROPARIN AND UFH |
| Albanyan A. |
- |
LACTADHERIN IS MORE SENSITIVE THAN ANNEXIN-V AT DETECTING PHOSPHATIDYLSERINE EXPOSURE WITHIN PLATELETS |
| Albayrak D. |
- |
CEREBRAL THROMBOSIS ASSOCIATED WITH HETEROZYGOUS FV LEIDEN MUTATION AND HIGH LIPOPROTEIN A LEVEL IN A GIRL WITH FACTOR XIII DEFICIENCY |
| Alberca I. |
- |
CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES |
| |
- |
ANTITHROMBIN CAMBRIDGE II (A384S): AN UNDERESTIMATED GENETIC RISK FACTOR FOR VENOUS THROMBOSIS |
| Alberio L. |
- |
DOSING LEPIRUDIN IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA AND VARIOUS DEGREES OF RENAL FUNCTION IMPAIRMENT |
| |
- |
CLINICAL APPROACH TO HEPARIN-INDUCED THROMBOCYTOPENIA |
| |
- |
MONITORING THROMBIN GENERATION IN WHOLE BLOOD BY ELECTROCHEMISTRY - A NEW APPROACH FOR SCREENING THROMBOPHILIC AND HEMOPHILIC RISKS |
| Albers M. |
- |
CHARACTERIZATION OF COMMERCIALLY AVAILABLE VWF-CONTAINING FVIII CONCENTRATES BY VWF MULTIMER ANALYSIS |
| Albers G.W. |
- |
ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTE ISCHEMIC STROKE PATIENTS |
| Albert F.W. |
- |
UNEXPLAINED PROLONGED PLATELET FUNCTION ANALYZER (PFA-100) CLOSURE TIME INDUCED BY SAMPLE ANTICOAGULANT |
| Albert J. |
- |
INCREASED THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) LEVELS IN EXPERIMENTAL HUMAN ENDOTOXEMIA IS CAUSED BY BOTH INFLAMMATORY RESPONSE AND THROMBIN GENERATION |
| Alberti A. |
- |
A MULTICENTER STUDY ON EARLY HEMORRHAGIC TRANSFORMATION IN ISCHEMIC STROKE: PRELIMINARY RESULTS |
| Alberto M.F. |
- |
EFFECT OF NYTROXYL (HNO) AND NITRIC OXIDE (NO) ON PROTEIN KINASE ACTIVATION PATHWAY IN HUMAN PLATELET |
| Alberto F. |
- |
HEMOSTATIC MARKERS AS PROGNOSTIC FACTORS IN ATRIAL FIBRILLATION. PRELIMINARY RESULTS OF A PROSPECTIVE STUDY |
| |
- |
LOW MOLECULAR THIOLS, PRO-COAGULANT STATE AND NATURAL ANTIOXIDANT SYSTEM IN HEMODIALYSIS PATIENTS |
| |
- |
D-DIMER VALUE AND ECHOCARDIOGRAPHIC CHANGES AS PREDICTORS OF THROMBOEMBOLIC COMPLICATIONS AFTER THE FONTAN OPERATION |
| Albiger N. |
- |
POLYMORPHISMS OF VON WILLEBRAND FACTOR (VWF) GENE PROMOTER MODULATE THE CORTICOSTEROID-MEDIATED INCREASE IN VWF LEVELS IN CUSHING'S SYNDROME: A POTENTIAL MODEL OF TRANSCRIPTIONAL REGULATION AND A NEW THROMBOTIC MARKER |
| Albisetti M. |
- |
PORT--CATH-RELATED THROMBOSIS AND POSTTHROMBOTIC SYNDROME IN PAEDIATRIC ONCOLOGY PATIENTS: THE PACTOP STUDY |
| |
- |
SELF-CONTROL OF ORAL ANTICOAGULATION USING A PORTABLE PROTHROMBIN TIME MONITOR IN PAEDIATRIC CARDIAC PATIENTS |
| Albisinni R. |
- |
ACQUIRED AND INHERITED PREDISPOSING CONDITIONS IN PATIENTS WITH RETINAL VEIN OCCLUSION |
| Albrecht S. |
- |
BLOOD EOSINOPHILS STORE AND EXPOSE TISSUE FACTOR (TF) PROMOTION OF TRANSENDOTHELIAL MIGRATION |
| Alcaraz A. |
- |
BILLIARY CIRRHOSIS: CONFORMATIONAL EFFECTS AND CONSEQUENCES OF THE OXIDATION OF HEPATIC SERPINS |
| Aldama A. |
- |
ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION |
| Aldemir H. |
- |
THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS |
| |
- |
FX DEFICIENCY: CHARACTERISTICS AND TREATMENT OUTCOME OF SEVEN CASES |
| |
- |
EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA |
| AlDieri R. |
- |
ORAL ANTICOAGULATION SEVERELY IMPAIRS THE FUNCTION OF THE PROTEIN C SYSTEM |
| Aledort L.M. |
- |
EFFICACY OF A FVIII/VWF CONCENTRATE AS REPLACEMENT THERAPY IN PREVENTING EXCESSIVE BLEEDING IN SUBJECTS WITH CONGENITAL VON WILLEBRAND DISEASE (VWD) WHO UNDERWENT SURGICAL OR INVASIVE PROCEDURES |
| |
- |
MTHFR C677T HOMOZYGOSITY AND RECURRENT FETAL LOSS |
| Aleil B. |
- |
MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES |
| Aleksanin S.S. |
- |
AN INCREASE OF CELL LETHALITY IN IRRADIATED VASCULAR ENDOTHELIUM AND PROBLEM OF HAEMOSTASIS |
| Alessandrello Liotta A. |
- |
PROTEIN Z PLASMA LEVELS IN DIFFERENT LOCALIZATIONS OF ATHEROSCLEROTIC DISEASE |
| |
- |
LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS |
| |
- |
ASSESSMENT OF CLOT LYSIS TIME TISSUE FACTOR-INDUCED BY EXOGENOUS T-PA IN HEALTHY SUBJECTS BY USING A MICROPLATE READER |
| |
- |
HEMORHEOLOGICAL PROFILE IN RETINAL VEIN OCCLUSION |
| Alessandriello Liotta A. |
- |
HYPERVISCOSITY AS A POSSIBLE DETERMINANT OF INFARCT SIZE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION |
| Alessi M. |
- |
A MULTICENTRE PROSPECTIVE OPEN-LABEL STUDY ASSESSING PHARMACOKINETICS, CLINICAL EFFICACY AND SAFETY OF A TRIPLE-SECURED FIBRINOGEN CONCENTRATE: FIBRINOGENE T-I |
| |
- |
DISRUPTION OF PAI-1 CIRCADIAN RHYTHM IN OBESE SUBJECTS MAY EXPLAIN A CHANGE IN THE TIME OF ONSET OF MYOCARDIAL INFARCTION |
| Alessi M.C. |
- |
OBESITY, METABOLIC SYNDROME, AND VENOUS THROMBOEMBOLISM |
| |
- |
RISK OF A FIRST VENOUS OR ARTERIAL EVENT IN CARRIERS OF A FAMILIAL THROMBOPHILIC DEFECT |
| |
- |
IDENTIFICATION OF 8 NOVEL MUTATIONS IN THE NON-MUSCLE MYOSIN HEAVY CHAIN 9 (MYH9) GENE IN 11 UNRELATED PATIENTS WITH MACROTHROMBOCYTOPENIA |
| Alessi M. |
- |
CYP 2C19*2 AND MDR1+3435C ALLELES CONTRIBUTE TO LOW RESPONSE TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME |
| Alessi M.C. |
- |
PAI-1 GENE HAPLOTYPES ARE ASSOCIATED WITH MYOCARDIAL INFARCTION OCCURRENCE IN NON SMOKERS: THE HIFMECH STUDY |
| Aléssio A.C.M. |
- |
EVALUATION OF MILD HHCY IN THE DEVELOPMENT OF ATHEROSCLEROSIS IN APOE-DEFICIENT AND NORMAL MICE |
| Alexander D. |
- |
TWO PATIENTS WITH TYPE III PROTEIN S DEFICIENCY WHO UNDERWENT CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS |
| Alexander S. |
- |
A NOVEL P2Y12 ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST THAT INHIBITS PLATELET AGGREGATION AND THROMBUS FORMATION IN RAT AND DOG MODELS |
| Alexandra J. |
- |
OVER-ANTICOAGULATION ASSOCIATED WITH COMBINED USE OF COUMARIN ANTICOAGULANTS AND TOPICAL ECONAZOLE OR BIFONAZOLE IN ELDERLY PATIENTS |
| Alexandrova E.N. |
- |
LONG-TERM OBSERVATION OF 280 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND 74 PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: 10-YEAR FOLLOW-UP |
| Alfinito F. |
- |
BUDD-CHIARI SYNDROME IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WITH PREVIOUS CEREBRAL VENOUS THROMBOSIS |
| Alfonsova E.V. |
- |
POSSIBLE MECHANISMS OF THE DEVELOPMENT OF DIC SYNDROME |
| Alfter K. |
- |
HEPARIN AND BLEEDING HISTORY IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS |
| Alguel G. |
- |
PREGNANCY OUTCOME IN WOMEN WITH THE LUPUS ANTICOAGULANT AND A HISTORY OF THROMBOEMBOLISM (TE) |
| |
- |
A HIGH PLATELET COUNT INDEPENDENTLY PREDICTS VENOUS THROMBOEMBOLISM IN CANCER PATIENTS |
| |
- |
SUCCESSFUL PREGNANCY OUTCOME IN A WOMAN WITH HOMOZYGOUS ANTITHROMBIN DEFICIENCY (99 LEUPHE MUTATION) |
| Alhaddabi H. |
- |
CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN |
| Alhenc-Gelas M. |
- |
ORGARAN CROSS REACTIVITY WITH HEPARIN INDUCED THROMBOCYTOPENIA ANTIBODIES: REPORT OF 12 CASES |
| |
- |
GENETIC ANALYSIS BY MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION IN PROTEIN S DEFICIENCY |
| Alhomsi K. |
- |
EVALUATION OF A NEW, AUTOMATED QUANTITATIVE FACTOR XIII ASSAY |
| Ali M. |
- |
DOSING EFFICACY AND SAFETY OF UNFRACTIONATED HEPARIN IN INFANTS WITH THROMBOTIC COMPLICATIONS |
| Aljada A. |
- |
INHIBITION OF CANCER AND INFLAMMATION-ASSOCIATED THROMBOSIS USING NOVEL INHIBITORS OF NFKB AND OXIDATIVE STRESS PATHWAYS |
| Alkayali A. |
- |
ROLE OF THYROID HORMONE ANALOGS IN ANGIOGENESIS AND THE DEVELOPMENT OF COLLATERALS IN RABBIT HIND LIMB ISCHEMIA MODEL |
| Allcott N. |
- |
CONSTITUTIVELY ACTIVE OR INACTIVE I DOMAINS AS PROBES FOR INTEGRIN BINDING TO COLLAGEN |
| Allemand E. |
- |
VENOUS THROMBOSIS DURING ORAL CONTRACEPTION IN NORMAL OR THROMBOPHILIC WOMEN WHO HAD REMAINED ASYMPTOMATIC DURING PAST PREGNANCIES |
| Allen D.J. |
- |
PLATELET ACTIVATION RESPONSE IS MORE SENSITIVE TO THROMBIN STIMULATION THAN IS PLATELET APOPTOSIS |
| Allen C. |
- |
QUALITY OF ANTICOAGULATION MANAGEMENT IN PRIMARY CARE PRACTICE |
| Al-Marwani A. |
- |
CHARACTERISATION OF THE MOLECULAR GENETIC DEFECTS UNDERLYING GLANZMANN'S THROMBASTHENIA IN JORDANIAN FAMILIES |
| Almasy L.A. |
- |
GENETIC DETERMINANTS OF NORMAL VARIATION IN ADAMTS-13 LEVELS: HERITABILITY ESTIMATE AND GENOME-WIDE SCAN |
| Almasy L. |
- |
MAPPING QUANTITIVE TRAIT NUCLEOTIDES (QTN) IN THE F12 GENE REVEALED THAT THE C46T IS THE MAIN FUNCTIONAL VARIANT |
| |
- |
GENETIC DETERMINANTS OF PLATELET-PLATELET AND PLATELET-LEUKOCYTE AGGREGATES. RESULTS FROM THE GAIT PROJECT |
| Almeida-Dias A. |
- |
ROLE OF PLATELET GLYCOPROTEIN IB-ALPHA POLYMORPHISM IN PLATELET REACTIVITY |
| Almenar L. |
- |
DYSFUNCTION ENDOTHELIAL AND ANGIOGENIC ACTIVITY IN CHRONIC HEART FAILURE: ROLE OF ORAL ANTICOAGULANT THERAPY |
| |
- |
INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND ANGIOGENIC ACTIVITY IN STABLE HEART FAILURE PATIENTS |
| Almus-Jacobs F. |
- |
THE ROLE OF PLATELET GLYCOPROTEIN VI IN ARTERIAL THROMBOSIS |
| Alobaidi M. |
- |
MAJOR OBSTETRIC HAEMORRGHAGE IN LATE TERMINATION OF PREGNANCY |
| |
- |
MAJOR OBSTETRIC HAEMORRHAGE IN LATE TERMINATION OF PREGNANCY |
| Aloeva M.A. |
- |
HEMOSTASIS DISORDERS MARKERS IN INTRACRACRANIAL MENONGIOMAS (IM) PATIENTS |
| Aloeva M.M.A. |
- |
APPLICATION OF LOW MOLECULAR-WEIGHT HEPARIN (NARDROPARINE) IN PATIENTS WITH LUNG CANCER |
| Alonso B. |
- |
ROLE OF 4G/5G PROMOTER POLYMORPHISM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN OUTCOME OF SEPSIS |
| Alonso A. |
- |
SEROTONERGIC MECHANISMS IN HAEMOSTASIS: A CONNECTION BETWEEN MAJOR DEPRESSION AND THROMBOTIC RISK |
| Alonso I. |
- |
RECURRENT ARTERIAL THROMBOSIS WITH FACTOR V LEIDEN HOMOZYGOCY |
| Alsabeh R. |
- |
CORRELATION OF PF4 ELISA (PF4) OPTICAL DENSITY RESULTS AND CLINICAL FINDINGS TO ACCURATELY DIAGNOSE HEPARIN INDUCED THROMBOCYTOPENIA (HIT) |
| Althabe M. |
- |
USE OF RECOMBINANT ACTIVATED FACTOR VII IN NON-HEMOPHILIC CHILDREN |
| Althaus H. |
- |
QUANTITATION OF D-DIMER BY LOCI TECHNOLOGY |
| Altiay G. |
- |
THROMBOSIS IN PATIENTS WITH LUNG CANCER AND THE EFFECTIVENESS OF LOW WARFARIN PROPHYLAXIS ON PATIENTS' SURVIVAL |
| Altisent C. |
- |
ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN |
| Altmann B. |
- |
PROTEIN DISULFIDE ISOMERASE (PDI) UNCOVERS TISSUE FACTOR (TF)-DEPENDENT FIBRIN FORMATION AFTER VESSEL INJURY |
| Altomare I. |
- |
MTHFR C677T HOMOZYGOSITY AND RECURRENT FETAL LOSS |
| Altomonte F. |
- |
RANDOMISED, OPEN, PROSPECTIVE, MULTICENTER PILOT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ACTIVATED RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN ACUTE INTRACEREBRAL HAEMORRHAGE IN PATIENTS TREATED WITH ORAL ANTICOAGULANT OR ANTIPLATELET AGENTS |
| Altun M. |
- |
RADIOSYNOVECTOMY WITH YTRIUM-90 AND RHENIUM-186 IN HEMOPHILIC ARTHROPATY |
| Altun A. |
- |
IS PLATELET HYPERREACTIVITY DEFINING STICKY PLATELET SYNDROME A GLOBAL PHENOMENON? THE STUDY OF DETERMINATON OF NORMAL VALUES IN TURKISH HEALTHY SUBJECTS |
| Altuncu E. |
- |
RECOMBINANT FVIIA USE IN THREE PRETERM NEONATES WITH DISSEMINATED INTRAVASCULAR COAGULATION |
| Alvarado L.R. |
- |
A NOVEL MUTATION IN EXON 10 OF FACTOR XIII SUBUNIT B |
| |
- |
FACTOR XIII PHARMACOKINETICS |
| Alvarado-Vazquez N. |
- |
EFFECT OF PROLAME, A 17 BETA-AMINOESTROGEN DERIVATIVE, ON CELL HEMOSTASIS |
| Alvarez L. |
- |
DEFICIENCY OF SRC HOMOLOGY 2 DOMAIN-CONTAINING INOSITOL 5-PHOSPHATASE 1 (SHIP1) AFFECTS PLATELET RESPONSES AND THROMBUS GROWTH |
| Alvarez H. |
- |
ANGIOGENIC GENE THERAPY WITH VASCULAR ENDOTHELIAL GROWTH FACTOR FOR TREATING INTERMITTENT CLAUDICATION |
| Alvarez M. |
- |
IMMUNE TOLERANCE INDUCTION WITH VIII-CONTAINING FACTOR VWF |
| Alvarez-Roman M.T. |
- |
RADIOSYNOVIORTHESIS IS NECESSARY IN HEMOPHILIC PATIENTS DESPITE PROHYLAXIS |
| Alves M. |
- |
RFVIIA IN THE TREATMENT OF GLANZMANN'S THROMBASTHENIA - CASE REPORT |
| Alves B.E. |
- |
HEMOSTATIC CHANGES IN BRAZILIAN SPOTTED FEVER |
| Alvi A. |
- |
A MUTATION IN EXON 27 OF THE VWF GENE CAUSING TYPE 2M AND TYPE 3 VON WILLEBRAND DISEASE IN THREE PATIENTS IN A FAMILY FROM THE WEST OF SCOTLAND |
| Alvisi P. |
- |
MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE |
| Alzadjali S. |
- |
CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN |
| Al-Zahrani F.M. |
- |
CHARACTERISATION OF PREDICTED OESTROGEN RESPONSE ELEMENTS IN THE ITGA2 GENE PROMOTER |
| Amano K. |
- |
DOUBLE MUTATION, A 2-BP DELETION AND VAL 211ILE, IN THE BLOOD COAGULATION FACTOR IX GENE IN A PATIENT WITH SEVERE HEMOPHILIA B |
| |
- |
FACTOR V DEFICIENCY DUE TO A NOVEL HOMOZYGOUS MUTATION: FV N468S, BUT NO BLEEDING TENDENCY |
| |
- |
ANALYSIS OF DISCREPANT ASSAY-DETERMINED ACTIVITY LEVELS OF FACTOR VIII ASSOCIATED WITH R531H MUTATION |
| |
- |
CONTINUOUS INFUSION OF VON WILLEBRAND FACTOR/FACTOR VIII CONCENTRATE IN PATIENTS WITH CONGENITAL VON WILLEBRAND DISEASE |
| |
- |
CHARACTERIZATION OF A LARGE DELETION THAT LEADS TO CONGENITAL FACTOR XIII DEFICIENCY |
| Amarenco P. |
- |
A ROLE FOR PLATELET ACTIVATION IN LACUNAR STROKE? |
| Amato M. |
- |
E-SELECTIN AND TFPI ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN STABLE CORONARY PATIENTS: THE BASELINE FINDINGS OF THE MIAMI STUDY |
| |
- |
ASSOCIATION OF TISSUE FACTOR A-603G GENOTYPE WITH CAROTID INTIMA-MEDIA THICKNESS IN SUBJECTS IN CARDIOVASCULAR RISK PREVENTION |
| Amaya M. |
- |
THERAPEUTIC ANTIBODIES AGAINST CD40 LIGAND, TNF-ALPHA AND VEGF SHARE MECHANISTIC FEATURES IN COMMON WITH PLATELET ACTIVATING ANTIBODIES IN HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) |
| |
- |
HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS |
| |
- |
PROSPECTIVE EVALUATION OF LABORATORY TESTS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA |
| Ambaglio C. |
- |
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA (CAMT): CLINICAL AND BIOLOGICAL CHARACTERIZATION OF FIVE NEW MUTATIONS |
| Ambily A. |
- |
AKT ACTIVATION BY PHOSPHAPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE IN HUMAN PLATELETS IS DEPENDENT ON EXTRACELLULAR CA2+ |
| Ameling C. |
- |
EFFECTS OF PARTICULATE MATTER AIR POLLUTION ON INFLAMMATION AND HAEMOSTASIS |
| Amelot A.A. |
- |
PLATELET FACTOR 4 (PF4/CXCL4) SEALS BLOOD CLOTS BY ALTERING THE STRUCTURE OF FIBRIN |
| Amelot A. |
- |
THROMBIN ADSORBED TO A FIBRIN CLOT CONFERS ANGIOGENIC AND HEMOSTATIC PROPERTIES ON ENDOTHELIAL PROGENITOR CELLS |
| Amengual O. |
- |
DIAGNOSTIC SIGNIFICANCE OF TESTING ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FOR THE ANTIPHOSPHOLIPID SYNDROME |
| |
- |
THE P38 MITOGEN-ACTIVATE PROTEIN KINASE MAPK) PATHWAY MEDIATES THE INDUCTION OF TISSUE FACTOR EXPRESSION BY PHOSPHATIDYLSERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODIES WITH LUPUS ANTICOAGULANT ACTIVITY |
| Ameziane N. |
- |
FACTOR V LEIDEN (G1691A) AND PROTHROMBIN (G20210A) GENOTYPING BY HIGH-RESOLUTION MELT ANALYSIS (HRM) AND SYTO 9 FLUORESCENT DYE ON THE ROTOR-GENE 6000 HRM |
| Amin S.N. |
- |
THROMBOPHILIA & RECURRENT FETAL LOSS: SHOULD WE SCREEN BOTH PARENTS ? |
| Amiral J.J. |
- |
INCIDENCE OF THE VARIOUS HEPARIN DEPENDENT ANTIBODY ISOTYPES IN A GROUP OF PATIENTS WITH HEPARIN INDUCED THROMBOCYTOPENIA |
| |
- |
FACTORS AFFECTING THE FACTOR VIII:C REACTIVITY WHEN TESTED IN PURIFIED SYSTEMS WITH CHROMOGENIC ASSAYS |
| Amiral J. |
- |
DEVELOPMENT AND VALIDATION OF A MULTIPLEXED FLUORESCENT BEAD-BASED IMMUNOASSAY FOR SIMULTANEOUS QUANTIFICATION OF COAGULATION AND FIBRINOLYSIS PARAMETERS IN HUMAN PLASMA |
| Amiral J.J. |
- |
MICROPARTICLES PROCOAGULANT ACTIVITY IN CITRATED PLASMA |
| |
- |
CLASSIFICATION OF FACTOR V-LEIDEN CARRIERS BY QUANTITATIVELY MEASURING ITS PROCOAGULANT ACTIVITY COMPARATIVELY TO THAT OF FACTOR V |
| |
- |
QUANTITATIVE MEASUREMENT OF FACTOR V-LEIDEN WITH A NEW ONE STEP, CALIBRATED, CLOTTING METHOD |
| |
- |
NEW APPROACH FOR DETECTION OF HEPARIN DEPENDENT ANTIBODIES AND RISK ASSESSMENT FOR HEPARIN INDUCED THROMBOCYTOPENIA |
| Amiri A. |
- |
INFLUENCE OF INHERITED THROMBOPHILIA WITH RECURRENT PREGNANCY LOSS |
| Amirkhosravi A. |
- |
HYPERCOAGULABILITY IN OVARIAN CANCER REVISITED: A PROSPECTIVE ANALYSIS OF COAGULATION AND PLATELET ACTIVATION MARKERS |
| |
- |
PROSPECTIVE EVALUATION OF LABORATORY TESTS FOR THE DIAGNOSIS OF HEPARIN-INDUCED THROMBOCYTOPENIA |
| |
- |
IMPACT OF TISSUE FACTOR-BEARING MICROPARTICLES DERIVED FROM TUMOR CELLS ON COAGULATION ACTIVATION |
| |
- |
BLOOD-BORNE BUT NOT ENDOTHELIAL CD40 PROMOTES EXPERIMENTAL LUNG METASTASIS |
| |
- |
THERAPEUTIC ANTIBODIES AGAINST CD40 LIGAND, TNF-ALPHA AND VEGF SHARE MECHANISTIC FEATURES IN COMMON WITH PLATELET ACTIVATING ANTIBODIES IN HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) |
| |
- |
ANTI-METASTASIS EFFICACY OF LOW MOLECULAR WEIGHT HEPARIN IN EXPERIMENTAL METASTASIS MODEL |
| Amistà P. |
- |
INTRACRANIAL STENTING IN FOUR PATIENTS WITH ACUTE ISCHEMIC STROKE |
| Amitrano L. |
- |
COMMON GENE MUTATIONS AND VENOUS THROMBOEMBOLISM: DISTINCT ROLES IN DIFFERENT CLINICAL SETTINGS |
| Amlie-Lefond C. |
- |
TPA IN CHILDREN WITH ARTERIAL ISCHEMIC STROKE: CASES FROM THE IPSS COMPARED WITH LITERATURE-BASED CASES |
| Ammar S. |
- |
ASSOCIATION OF HYPERHOMOCYSTEINEMIA WITH RESTENOSIS |
| Ammollo T.C. |
- |
LPS-STIMULATED MONOCYTES INHIBIT FIBRINOLYSIS THROUGH A TISSUE FACTOR (TF)-DEPENDENT, TAFI-MEDIATED MECHANISM |
| Amor Otero M. |
- |
RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN THE TREATMENT OF CRITICAL HAEMORRHAGE. A SINGLE CENTRE EXPERIENCE |
| Amor Otero M.A. |
- |
"PRIMARY" PROPHYLACTIC TREATMENT WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) DURING INMUNE TOLERANCE IN A HAEMOPHILIC CHILD |
| Amore C. |
- |
ANTI-INFLAMMATORY EFFECS OF CLOPIDOGREL IN THE MOUSE |
| |
- |
PERSISTENT PLATELET ACTIVATION IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH LOW DOSES OF ASPIRIN |
| |
- |
GLYCOGEN SYNTHASE KINASE-3 NEGATIVELY REGULATES TISSUE FACTOR GENE EXPRESSION IN MONOCYTES INTERACTING WITH ACTIVATED PLATELETS |
| |
- |
LEPTIN INDUCES TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES |
| Amoriello A.A.A. |
- |
A B3 ASP217VAL SUBSTITUTION IN A PATIENT WITH VARIANT GLANZMANN THROMBATHENIA SEVERELY AFFECTS INTEGRIN AIIBB3 FUNCTIONS |
| Amoriello A. |
- |
DESMOPRESSIN IN PATIENTS WITH CONGENITAL DISORDERS OF PRIMARY HAEMOSTASIS: FOUR YEAR PROSPECTIVE EVALUATION |
| Anabuki J. |
- |
PHARMACOLOGICAL CHARACTERIZATION OF AN ORAL DIRECT THROMBIN INHIBITOR, MCC-977: HIGH THROMBIN SPECIFICITY AND LOW HEMORRHAGIC PROFILE |
| |
- |
THE ANTI-COAGULANT AND THE ANTI-THROMBOTIC EFFECT OF MCC-977, A NOVEL ORALLY-ACTIVE THROMBIN INHIBITOR |
| Anand S.S. |
- |
COMPARISON OF IMPEDANCE WHOLE BLOOD AGGREGATION AND OPTICAL PLATELET-RICH PLASMA AGGREGATION TO MEASURE THE ANTIPLATELET EFFECT OF ASPIRIN IN HEALTHY CONTROLS AND IN PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD) |
| Anastasio R. |
- |
PERIOPERATIVE BRIDGING THERAPY WITH LOW MOLECULAR WEIGH HEPARIN IN PATIENTS REQUIRING INTERRUPTION OF LONG-TERM ORAL ANTICOAGULANT THERAPY |
| |
- |
LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY |
| |
- |
ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS |
| |
- |
THE PERSISTANCE OF RESIDUAL VEIN THROMBOSIS, AFTER AN EPISODE OF DEEP VEIN THROMBOSIS, AND THE RISK OF NEW OVERT CANCER AND CARDIOVASCULAR DISEASE |
| Anastasopoulou I. |
- |
DOES ADMINISTRATION OF LANSOPRAZOLE AFFECT ASA ANTIPLATELET FUNCTION IN HIGH RISK CARDIOVASCULAR PATIENTS? PRELIMINARY RESULTS |
| |
- |
SAFETY AND EFFICACY OF TINZAPARIN ADMINISTRATION DURING PREGNANCY |
| |
- |
COAGUCHEK XS IN COMPARISON TO BCS ANALYZER. RESULTS IN AN OUTPATIENT ANTICOAGULATION CLINIC, FOCUSED IN METAL VALVE DISEASE |
| |
- |
PRELIMINARY RESULTS ON EFFECTIVENESS AND SAFETY OF COMBINED ANTICOAGULANT AND ANTIPLATELET THERAPY |
| |
- |
CONTRIBUTION OF ROTATION THROMBOELASTOGRAPHY (RT) IN PERIOPERATIVE MANAGEMENT OF PATIENTS WITH GLAZMANN'S THROMBASTHENIA (GT) |
| Ancona E. |
- |
RECOMBINANT HUMAN ACTIVATED PROTEIN C (RHAPC) IN PIG-TO-PRIMATE XENOTRANSPLANTATION |
| Anders B. |
- |
PLATELET EP3 RECEPTORS AS TARGETS FOR ANTITHROMBOTIC AGENTS - COMPARISON OF DG-041 WITH ASPIRIN AND AR-C69931 |
| Anders R. |
- |
EP3 RECEPTORS - A NEW TARGET FOR INHIBITION OF PLATELET AGGREGATION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION |
| Andersen S. |
- |
EVALUATION OF THROMBOELASTOGRAPHY (TEG) ASSAYS FOR MONITORING EX VIVO EFFECT OF RFVIIA (NOVOSEVEN) IN HAEMOPHILIA A AND B PATIENTS |
| Andersen E. |
- |
EVALUATION OF THROMBOELASTOGRAPHY (TEG) ASSAYS FOR MONITORING EX VIVO EFFECT OF RFVIIA (NOVOSEVEN) IN HAEMOPHILIA A AND B PATIENTS |
| Andersen T.O. |
- |
EXPRESSION OF THE TFPI V264M MUTANT IN VASCULAR CELL CULTURES INVOLVES STABILITY OF MRNA |
| Andersen M.D. |
- |
FXIII VARIANTS WITH ALTERED THROMBIN ACTIVATION RATES |
| Andersen A.S. |
- |
FXIII VARIANTS WITH ALTERED THROMBIN ACTIVATION RATES |
| Andersen T.O. |
- |
TISSUE FACTOR PATHWAY INHIBITOR (TFPI) POLYMORPHISMS, HORMONE REPLACEMENT THERAPY (HRT) AND RISK OF VENOUS THROMBOEMBOLISM (VTE) |
| Andersen M.D. |
- |
PROBING THE ORIGINS OF ACTIVITY ENHANCEMENT IN FACTOR VIIA (FVIIA) VARIANTS BY HYDROGEN EXCHANGE MASS SPECTROMETRY (HX-MS) |
| Andersen K.V. |
- |
IMPROVED PROCOAGULANT AND PHARMACOKINETIC PROPERTIES OF TWO NOVEL RECOMBINANT HUMAN FACTOR VIIA VARIANTS PREPARED BY DIRECTED MOLECULAR EVOLUTION AND RATIONAL DESIGN |
| Anderson D.R. |
- |
PSYCHOLOGICAL IMPACTS OF GENETIC TESTING FOR THROMBOPHILIA ON FIRST DEGREE RELATIVES OF PATIENTS WITH VENOUS THROMBOEMBOLISM AND A THROMBOPHILIA A PILOT STUDY |
| Anderson F.A. |
- |
EFFECT OF BLOOD SALVAGE AND RE-INFUSION ON VTE COMPLICATIONS IN PATIENTS UNDERGOING ELECTIVE MAJOR ORTHOPEDIC SURGERY |
| Anderson D. |
- |
EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY |
| Anderson D.R. |
- |
A PILOT STUDY TO ASSESS THE FEASIBILITY OF A MULTICENTER TRIAL FOR THE MANAGEMENT OF ASYMPTOMATIC PERSONS WITH A THROMBOPHILIA |
| Anderson D. |
- |
DALTEPARIN THROMBOPROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH SEVERE RENAL INSUFFICIENCY: THE DIRECT STUDY |
| Anderson F.A. |
- |
LATE BREAKING CLINICAL TRIAL: A LARGE-SCALE, GLOBAL OBSERVATIONAL STUDY OF VENOUS THROMBOEMBOLISM RISK AND PROPHYLAXIS IN THE ACUTE HOSPITAL CARE SETTING: THE ENDORSE STUDY |
| Anderson D. |
- |
EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES |
| Anderson D.R. |
- |
ACCURACY AND USEFULNESS OF A CLINICAL PREDICTION RULE AND D-DIMER TESTING IN EXCLUDING DEEP VEIN THROMBOSIS (DVT) IN CANCER PATIENTS |
| Andersson M. |
- |
CPU INHIBITION WITH AZD9684: PROFIBRINOLYTIC EFFECTS IN ACUTE PE PATIENTS |
| Andersson E. |
- |
DALTEPARIN SHORTENS HUMAN LABOR |
| Andersson M. |
- |
A CHROMOGENIC METHOD FOR DETERMINATION OF FIXA IN PURIFIED PREPARATIONS |
| Andjelkovic N. |
- |
COAGULATION ABNORMALITIES IN WOMEN WITH VERIFIED MENORRHAGIA IS IT TIME FOR INCLUSION OF COAGULATION SCREENING IN DIAGNOSTIC ALGORITHM? |
| Ando T. |
- |
FACTOR V DEFICIENCY DUE TO A NOVEL HOMOZYGOUS MUTATION: FV N468S, BUT NO BLEEDING TENDENCY |
| Ando Y. |
- |
ACTIVATED PROTEIN C INCREASES TISSUE FACTOR EXPRESSION ON HUMAN UMBILICAL ENDOTHELIAL CELL BY EPCR-DEPENDENT BUT PAR-1-INDEPENDENT MANNER |
| Andolj[scaron]ek D. |
- |
INHIBITOR DEVELOPMENT IN 3 PATIENTS WITH HEMOPHILIA A AFTER INTENSIVE EXPOSURE TO FVIII CONCENTRATES BY CONTINUOUS INFUSION DATA FROM SLOVENIA |
| Andon Saavedra C. |
- |
SPANISH REGISTRY OF HEPARIN-INDUCED THROMBOCYTOPENIA (RETIH). PRELIMINARY DATA |
| |
- |
"PRIMARY" PROPHYLACTIC TREATMENT WITH RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) DURING INMUNE TOLERANCE IN A HAEMOPHILIC CHILD |
| Andón Saavedra C. |
- |
RECOMBINANT ACTIVATED FACTOR VII (RFVIIA) IN THE TREATMENT OF CRITICAL HAEMORRHAGE. A SINGLE CENTRE EXPERIENCE |
| Andrade-Gordon P. |
- |
PROTEASE-ACTIVATED RECEPTOR 2 (PAR-2) A NOVEL TARGET TO PREVENT FIX INHIBITOR FORMATION |
| Andre P. |
- |
PRT060128, A NOVEL, DIRECT-ACTING ORALLY AVAILABLE P2Y12 ANTAGONIST, CONFERS SUPERIOR ANTITHROMBOTIC ACTIVITY OVER CLOPIDOGREL IN A MOUSE THROMBOSIS MODEL |
| |
- |
INITIAL INTRAVENOUS EXPERIENCE WITH PRT060128 (PRT128), AN ORALLY-AVAILABLE, DIRECT-ACTING, AND REVERSIBLE P2Y12 INHIBITOR |
| Andre S. |
- |
EXPOSED MANNOSYLATION ON THERAPEUTIC FACTOR VIII MEDIATES ITS ENDOCYTOSIS BY HUMAN DENDRITIC CELLS LEADING TO ACTIVATION OF CD4+ T LYMPHOCYTES |
| Andre P. |
- |
DIFFERENTIAL EFFECTS OF ANTI-PLATELET DRUGS ON THROMBUS FORMATION AND THROMBUS STABILITY |
| |
- |
ANTAGONISM OF INTRINSIC PATHWAY INHIBITS TISSUE FACTOR (TF)-INITIATED COAGULATION IN A PLATELET-DEPENDENT WHOLE BLOOD FLOW ASSAY |
| André E. |
- |
ALL PROTEIN S (PS) EPIDERMAL GROWTH FACTOR LIKE DOMAINS (EGFS) SIGNIFICANTLY PARTICIPATE TO ACTIVATED PROTEIN C (APC) COFACTOR ACTIVITY |
| Andre P. |
- |
MEASUREMENT OF THROMBUS STABILITY PREDICTS CORONARY EVENTS POST-PERCUTANEOUS CORONARY INTERVENTION (PCI) |
| Andreassen A.K. |
- |
ELEVATED SERUM LEVELS OF LIGHT IN PULMONARY ARTERIAL HYPERTENSION-POTENTIAL INVOLVEMENT IN THROMBUS FORMATION |
| Andréasson A.C. |
- |
THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 REDUCES THROMBUS FORMATION IN A RAT MODEL |
| Andreeva T.A. |
- |
EFFICACY AND SAFETY OF FVIII WITH PEGYLATED LIPOSOMES IN HAEMOPHILIA A |
| Andrei-Selmer C. |
- |
SEVERE NEONATAL ALLOIMMUNE THROMBOCYTOPENIA CAUSED BY LOW-AVIDITY ANTI-HPA-1A ALLOANTIBODIES |
| Andreozzi G.M. |
- |
GRADUATED COMPRESSION STOCKINGS (GCS) VERSUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR PREVENTION OF DEEP VEIN THROMBOSIS (DVT) AFTER KNEE ARTHROSCOPY (KA). A RANDOMISED STUDY (KANT) |
| |
- |
BENIGN OUTCOME OF OBJECTIVELY PROVEN SPONTANEOUS RECANALIZATION OF INTERNAL CAROTID ARTERY OCCLUSION: LONG-TERM FOLLOW UP |
| |
- |
INADEQUATE CARDIOVASCULAR PREVENTION AND DIAGNOSTIC VASCULAR GUIDELINES ADHERENCE IN OUTPATIENTS: AN OBSERVATIONAL STUDY IN A COHORT OF NORTHERN ITALY |
| Andrews R.K. |
- |
RAPID LIGAND-INDUCED DIMERIZATION OF PLATELET GLYCOPROTEIN VI |
| |
- |
CONTROL SHEDDING OF GPIB-IX-V AND GPVI BY ADAM FAMILY METALLOPROTEINASES |
| |
- |
PROGRAMMED AUTOLOGOUS CLEAVAGE OF PLATELET RECEPTORS |
| Androutsopoulos G. |
- |
INHERITED THROMBOPHILIA: INCIDENCE AND IMPACT ON PERINATAL OUTCOME IN SOUTH-WESTERN GREECE |
| |
- |
FV LEIDEN, FII G20210A AND MTHFR T677T GENOTYPES: IS THEIR EVALUATION A USEFUL TOOL IN THE ETIOLOGICAL APPROACH OF THE EARLY RECURRENT PREGNANCY LOSSES IN THE GREEK POPULATION? |
| Anelli T. |
- |
MECHANISMS COUPLING PROTEIN FOLDING AND TRANSPORT AT THE ER-GOLGI INTERFACE: ROLE IN F5F8D AND OTHER DISEASES |
| Anfosso F. |
- |
COMPLEX MECHANISMS CONTROLLING THE THROMBIN-INDUCED GENERATION OF ENDOTHELIAL MICROPARTICLES |
| Angchaisuksiri P. |
- |
PROTEIN C MUTATIONS IN THAI PATIENTS WITH VENOUS THROMBOEMBOLISM |
| |
- |
FIBRINOGEN THR312ALA BUT NOT FXIIIA VAL34LEU AND FXIIIB HIS95ARG POLYMORPHISMS ASSOCIATED WITH THAI DEEP VENOUS THROMBOSIS |
| Angeloni F. |
- |
COMPARISON OF THE ASSERACHROM VON WILLEBRAND FACTOR ANTIGEN ASSAY AND THE LIATEST VWF ASSAY AUTOMATED ON THE AMAX 200 COAGULATION ANALYZER IN HUMAN AND CANINE PLASMA SAMPLES |
| Angenent W. |
- |
INHERENT VARIATION INDONOR PLATELET REACTIVITY CONTRIBUTES TO THE QUALITY OF APHERESIS PLATELETS |
| |
- |
A COMPREHENSIVE STUDY OF CANDIDATE GENES IN TWO SIGNALLING PATHWAYS TO IDENTIFY GENETIC VARIANTS THAT REGULATE PLATELET RESPONSIVENESS TO COLLAGEN AND ADP |
| |
- |
THE EFFECT OF APHERESIS ON DONORS' PLATELETS |
| |
- |
DIFFERENCES IN PLATELET RESPONSE TO ADP AND CRP ARE CORRELATED WITH VARIATION IN THE RESTING PLATELET TRANSCRIPTOME |
| Angerami R.N. |
- |
HEMOSTATIC CHANGES IN BRAZILIAN SPOTTED FEVER |
| Angles-Cano E. |
- |
CORTICAL NEURONS AGGREGATE IN RESPONSE TO PLASMIN FORMED AT THEIR SURFACE BY TPA |
| Angos V. |
- |
EFFECT OF AGING ON PLASMINOGEN ACTIVATOR INHIBITOR-1 EXPRESSION IN RAT TISSUES. POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND CARDIOVASCULAR RISK |
| Ankri A. |
- |
COMPARISON OF TWO WHOLE BLOOD PLATELET FUNCTION ASSAYS: PFA-100 AND A NEW MULTIPLE ELECTRODE AGGREGOMETRY (MULTIPLATE) FOR CONTROL OF ASPIRIN AND/OR CLOPIDOGREL EFFECT |
| Annichino-Bizzacchi J.M. |
- |
SIMULTANEOUS BLEEDING AND THROMBOSIS AS THE INITIAL PRESENTATION OF SUPERWARFARIN POISONING |
| |
- |
ANALYSIS OF THE GENETIC EXPRESSION OF INFLAMMATORY MEDIATORS IN MONONUCLEAR CELLS FROM DEEP VENOUS THROMBOSIS PATIENTS |
| |
- |
HEMOSTATIC CHANGES IN BRAZILIAN SPOTTED FEVER |
| |
- |
MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF FVIII MUTATIONS IN A FEMALE WITH SEVERE HEMOPHILIA A |
| |
- |
EVALUATION OF MILD HHCY IN THE DEVELOPMENT OF ATHEROSCLEROSIS IN APOE-DEFICIENT AND NORMAL MICE |
| |
- |
DAPSONE TREATMENT IN STEROID-DEPENDENT OR REFRACTORY ADULT ITP PATIENTS CAN AVOID IMMEDIATE SPLENECTOMY AFTER STEROID FAILURE |
| |
- |
DUAL GENE TRANSFER OF FGF-2 AND PDGF-BB USING PLASMID DNA PROMOTES EFFECTIVE ANGIOGENESIS AND ARTERIOGENESIS IN A RODENT MODEL OF HINDLIMB ISCHEMIA |
| |
- |
ANALYSIS OF MICROPARTICLES IN DEEP VENOUS THROMBOSIS AND ANTIPHOSPHOLIPID SYNDROME PATIENTS AND CARRIERS OF LEIDEN FACTOR V |
| |
- |
THE ROLE OF FACTOR VIII IN THE DEVELOPMENT OF ATHEROSCLEROTIC LESIONS IN MURINE MODELS |
| Anosov A. |
- |
ENOXAPARIN VERSUS HEPARIN PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM AFTER ABDOMINAL ONCOLOGIC SURGERY: A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL |
| Ansell J. |
- |
EFFICACY AND SAFETY OF WARFARIN MANAGEMENT IN US ANTICOAGULATION CLINICS |
| |
- |
FACTOR XA OR THROMBIN: IS FACTOR XA A BETTER TARGET |
| Anson J. |
- |
VICENZA MUTATION R1205H IDENTIFIED IN TWO TYPE 1 VON WILLEBRAND DISEASE FAMILIES FROM ISRAEL |
| Antevska Z. |
- |
HOSPITALISATION FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD- IS IT ALWAYS NECESSARY? |
| |
- |
A RARE CONGENITAL BLEEDING DISORDER: F.VII DEFICIENCY (CASE REPORT) |
| Antoine G. |
- |
MILD CONGENITAL ADAMTS13 DEFICIENCY DUE TO ONE MISSENSE MUTATION TOGETHER WITH FOUR AMINO ACID POLYMORPHISMS IN A PATIENT WITH FAMILIAL RECURRENT ISCHEMIC STROKE |
| Antonaci F.C. |
- |
FACTOR VIIA-ANTITHROMBIN COMPLEXES IN HUMAN PLASMA |
| Antonelli C. |
- |
A PROPOSAL OF SCORING SYSTEM IN ASSESSMENT OF THROMBOTIC RISK IN CANCER PATIENT. A MONOCENTRIC STUDY |
| Antonelli F. |
- |
APPLICABILITY OF D-DIMER IN RULING OUT VENOUS THROMBOEMBOLISM (VTE) IN ELDERLY MEDICAL PATIENTS: COMPARISON BETWEEN IMMUNOTURBIDIMETRIC AND ELISA (ELFA) METHODS |
| Antoniak S. |
- |
VIRAL MYOCARDITIS IS A HYPERCOAGULATIVE STATE. INCREASED TISSUE FACTOR EXPRESSION AND PLASMA THROMBOGENICITY |
| Antonijevic N.M. |
- |
INVESTIGATION OF ACQUIRED VON WILLEBRAND'S SYNDROME IN PATIENTS WITH HYPOTHYROIDISM |
| Antonijevic N. |
- |
THE 3'UTR PROTHROMBIN GENE POLYMORPHISMS IN THROMBOHILIC SERBIAN POPULATION |
| Antonino M. |
- |
EFFECT OF BIVALIRUDIN VS. BIVALIRUDIN WITH EPTIFIBATIDE ON PLATELET ACTIVATION AND AGGREGATION IN PATIENTS RECEIVING CHRONIC CLOPIDOGREL THERAPY UNDERGOING ELECTIVE PCI |
| Antonioli E. |
- |
A SURVEY ON POST-SURGERY OUTCOMES IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA IN A RETROSPECTIVE COHORT |
| Antoniucci D. |
- |
LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS |
| |
- |
CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY |
| |
- |
ASSOCIATION OF THE G681A POLYMORPHISM OF CYP2C19 GENE WITH RESPONSE VARIABILITY TO DUAL ANTIPLATELET TREATMENT IN HIGH RISK VASCULAR DISEASE PATIENTS |
| Antonucci E. |
- |
MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY |
| |
- |
POST-TREATMENT PLATELET FUNCTION PREDICTS MYOCARDIAL INJURY IN ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY PCI |
| |
- |
THE QUALITY OF ANTICOAGULATION ON FUNCTIONAL OUTCOME AND MORTALITY FOR TIA/STROKE IN ATRIAL FIBRILLATION PATIENTS |
| |
- |
PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS |
| |
- |
RISK OF BLEEDING IN VERY OLD ATRIAL FIBRILLATION PATIENTS ON WARFARIN: RELATIONSHIP WITH AGEING AND CHADS2 SCORE |
| |
- |
CLINICAL DETERMINANTS OF PLATELET FUNCTION IN PATIENTS WITH CAD UNDERGOING CORONARY ANGIOGRAPHY AND TREATED BY DUAL ANTIPLATELET THERAPY |
| |
- |
QUALITY OF OAT AND VTE RECURRENCE |
| |
- |
ROLE OF D-DIMER IN COMBINATION WITH F1+2, RVO AND THROMBOPHILIA IN THE RISK OF RECURRENCE OF PATIENTS WITH A FIRST VTE EPISODE AFTER OAT WITHDRAWA |
| Antovic A. |
- |
OVERALL HAEMOSTASIS POTENTIAL IN PATIENTS WITH VENOUS THROMBOSIS BEFORE, DURING AND AFTER ANTICOAGULANT TREATMENT |
| Antovic J.P. |
- |
INCREASED THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI) LEVELS IN EXPERIMENTAL HUMAN ENDOTOXEMIA IS CAUSED BY BOTH INFLAMMATORY RESPONSE AND THROMBIN GENERATION |
| Antovic A.M. |
- |
FIBRIN GEL POROSITY: COMPARISON OF TWO LABORATORY ASSAYS |
| |
- |
FIBRIN GEL POROSITY RELATES TO GLYCOSYLATED HAEMOGLOBIN IN PATIENTS WITH TYPE 1 DIABETES |
| Antovic J. |
- |
PREANALYTICAL CONDITIONS INFLUENCING FLOW CYTOMETRIC DETERMINATION OF PLATELET-DERIVED MICROPARTICLES (PDMP) |
| |
- |
COAGULATION ABNORMALITIES IN WOMEN WITH VERIFIED MENORRHAGIA IS IT TIME FOR INCLUSION OF COAGULATION SCREENING IN DIAGNOSTIC ALGORITHM? |
| Antovic J.P. |
- |
COMPARISON OF THREE DIFFERENT TAFI ASSAYS IN PATIENTS WITH ACUTE CORONARY SYNDROME |
| Antrobus R. |
- |
IDENTIFICATION OF NOVEL TYROSINE PHOSPHORYLATED SIGNALLING PROTEINS FOLLOWING IIb3-MEDIATED PLATELET SPREADING: INVOLVEMENT OF THE IMMUNOGLOBULIN SUPERFAMILY MEMBERS G6B-B AND G6F, AND THE NOVEL PLATELET ADAPTER DOK-3 |
| Antunes M. |
- |
RFVIIA IN THE TREATMENT OF GLANZMANN'S THROMBASTHENIA - CASE REPORT |
| Appa R. |
- |
INVESTIGATION OF HUMAN RECOMBINANT FVIIA METABOLISM IN A PERFUSED RAT LIVER MODEL |
| Appaloop M.V. |
- |
APPLICATION OF AUTOLOGOUS RED BLOOD CELLS CONCENTRATE DERIVED FROM UMBILICAL CORD BLOOD FOR THERAPY OF ANAEMIC NEONATES |
| Appel I.M. |
- |
AGE-RELATED CHANGES BY ASPARAGINASE ON COAGULATION AND FIBRINOLYSIS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) |
| Appelbom H. |
- |
ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PLASMA FROM PATIENTS WITH AMI DURING ANTITHROMBOTIC TREATMENT |
| Appendino G. |
- |
EFFECTS OF 8-PRENYLNARINGENIN, A NOVEL PHYTOESTROGEN, ON HUMAN PLATELETS |
| Apperley J. |
- |
ATTEMPTED ERADICATION OF HIGH RESPONDING FVIII INHIBITOR BY ALLOGENEIC BONE MARROW TRANSPLANTATION |
| Apperson-Hansen C. |
- |
ANTICOAGULANT RESPONSES IN PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN COMPARED TO UNFRACTIONATED HEPARIN FOR TEE GUIDED CARDIOVERSION OF ATRIAL FIBRILLATION: RESULTS FROM THE ASSESSMENT OF CARDIOVERSION USING TRANSESOPHAGEAL ECHOCARDIOGRAPHY (ACUTE |
| Appiah Kubi K. |
- |
RESEARCH IN CELL APOPTOSIS |
| |
- |
RESEARCH IN CELL APOPTOSIS |
| Appleby J.A. |
- |
REGULATION OF THE PLATELET PROCOAGULANT RESPONSE |
| |
- |
ACTIVATED PLATELETS INDUCE TISSUE FACTOR PATHWAY INHIBITOR IN PERIPHERAL BLOOD MONOCYTES |
| |
- |
DESIGN OF A PLATELET SUBSTITUTE UTILISING HOST FIBRINOGEN TO ENHANCE HAEMOSTASIS |
| Appleby N. |
- |
ONCE DAILY TINZAPARIN SODIUM (175 INTERNATIONAL UNITS PER KG) IS SAFE AND EFFECTIVE FOR ANTENATAL THROMBOPROPHYLAXIS IN HIGH RISK PREGNANCIES AND FOR TREATMENT OF ANTENATAL VENOUS THROMBOEMBOLIC EVENTS |
| Aquino J.W. |
- |
FACTOR V INHIBITORS: DIVERSITY IN CLINICAL PRESENTATION |
| Araba F. |
- |
FONDAPARINUX IS A SAFE AND EFFECTIVE ALTERNATIVE ANTICOAGULANT IN PREGNANT WOMEN WITH INTOLERANCE TO LOW-MOLECULAR- WEIGHT HEPARINS AND HEPARINOIDS |
| Arachiche A. |
- |
THE RAPID PROCOAGULANT MEMBRANE SCRAMBLING INDUCED BY CALCIUM IONOPHORES IN PLATELETS AND LYMPHOCYTES IS DIFFERENT FROM THAT INDUCED BY THAPSIGARGIN IN PLATELETS: DEMONSTRATION WITH CYCLOSPORIN A |
| Aracil E. |
- |
DEEP VEIN THROMBOSIS AND THE RISK OF RECURRENT PULMONARY EMBOLISM |
| Arad A. |
- |
ANTI CD20 MONOCLONAL ANTIBODIES THERAPY FOR RESISTANT ANTIPHOSPHOLIPID SYNDROME |
| Arahara M. |
- |
PATHOPHYSIOLOGICAL MECHANISMS OF VASCULOPATHY IN SYSTEMIC SCLERODERMA (SSC): PLATELET ACTIVATION INDUCED BY APL IS ASSOCIATED WITH ARTERIAL THROMBOSES AND DIGITAL PITTING SCAR IN SSC PATIENTS |
| Arai J. |
- |
QUANTIFICATION OF BLOOD COAGULATION FACTOR XIII ANTIGEN BY LATEX IMMUNOTURBIDIMETRIC ASSAY |
| Araki S. |
- |
2-AG PLAY A ROLE ON ASPIRIN RESISTANCE IN TYPE 2 DIABETES |
| Araujo G.S. |
- |
HEMOSTATIC CHANGES IN BRAZILIAN SPOTTED FEVER |
| Arber C. |
- |
PLATELET REFRACTORINESS DUE TO ANTI-HLA AND ANTI-HPA-5A ALLOANTIBODIES: CLINICAL MANAGEMENT DURING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION |
| Arbring K. |
- |
SNAPSHOT OF WARFARIN TREATMENT IN DIFFERENT SETTINGS: A CROSS SECTION STUDY IN SWEDISH PRIMARY HEALTH CARE CENTERS VS ANTICOAGULATION CLINICS |
| Arcari A. |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND WHITE BLOOD CELL COUNT WITH PHYSICAL ACTIVITY IN HEALTHY SUBJECTS |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN AND ALCOHOL INTAKE IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
ASSOCIATION OF C-REACTIVE PROTEIN, OBESITY AND METABOLIC SYNDROME IN HEALTHY MEN AND WOMEN FROM THE MOLI-SANI POPULATION |
| |
- |
FIBRIN D-DIMERS IS ASSOCIATED WITH PREVALENT CARDIOVASCULAR EVENTS IN THE MOLI-SANI STUDY |
| Archararit N. |
- |
NORMALIZED PHOSPHATIDYLSERINE EXPRESSION ON RED BLOOD CELLS IN CHILDREN WITH SEVERE THALASSEMIA DISEASE AFTER STEM CELL TRANSPLANTATION |
| Arcozzi C. |
- |
TISSUE FACTOR AND COAGULATION FACTOR VII LEVELS DURING ACUTE MYOCARDIAL INFARCTION CONTRIBUTE TO PREDICT MORTALITY AND RE-INFARCTION |
| Ardeshiri R. |
- |
FACTOR XI DEFICIENCY IN SOUTHERN IRAN AND REVIEW OF LITERATURE |
| Aref S. |
- |
CLINICAL SIGNIFICANCE OF MEAN PLATELETS VOLUME IN CORONARY ARTERY DISEASE |
| |
- |
CLINICAL SIGNIFICANCE OF MEAN PLATELETS VOLUME IN CORONARY ARTERY DISEASE |
| Arellano A.R. |
- |
FACTOR IX MALM IS ASSOCIATED WITH VENOUS THROMBOSIS |
| |
- |
GENETIC VARIATION IN THE CYP4V2 GENE IS ASSOCIATED WITH VENOUS THROMBOSIS |
| |
- |
A FEASIBILITY STUDY OF RISK STRATIFICATION FOR RECURRENT VENOUS THROMBOSIS BY MULTIPLE SNP ANALYSIS |
| Arenaz I. |
- |
CYCLOOXYGENASE-2 IS CRITICAL FOR HYDROGEN PEROXIDE-MEDIATED WOUND REPAIR IN HUMAN ENDOTHELIAL CELLS |
| |
- |
PARACRINE UP-REGULATION OF MONOCYTE CYCLOOXYGENASE-2 BY PLATELETS: ROLE OF TGF-BETA1 |
| Arepally G.M. |
- |
TISSUE FACTOR AROUND DERMAL VESSELS HAS BOUND FACTOR VII IN THE ABSENCE OF INJURY |
| |
- |
DEVELOPING ANTIDOTE CONTROLLED ANTIPLATELET THERAPIES BY TARGETING THE VWF - GP IB-IX-V INTERACTION |
| Arghirescu S. |
- |
HEMOSTATIC EXPRESSION OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDREN |
| Arias-Salgado E. |
- |
CORRELATION BETWEEN SCD40L LEVELS AND METALLOPROTEINASE EXPRESSION WITH THE PLATELET FUNCTIONAL RESPONSE IN IMMUNOLOGICAL DISEASES |
| Arias-Salgado E.G. |
- |
INTEGRIN-LINKED KINASE (ILK) IN PLATELET ALPHAIIB-BETA3 SIGNALING AND ARTERIAL THROMBOSIS |
| Arici V. |
- |
EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS |
| Ariens R.A.S. |
- |
RECOMBINANT BBETA-LYS448 IS ASSOCIATED WITH SIGNIFICANT CHANGES IN FIBRIN STRUCTURE AND CLOT RIGIDITY |
| |
- |
THE LOCALISATION OF A NOVEL FACTOR XIIIB BINDING SITE ON THE ALPHA CHAIN OF FIBRINOGEN AND ITS ROLE IN FXIII DISSOCIATION |
| |
- |
MULTIPLE SITES OF FXIIIA ARE INVOLVED IN THE BINDING INTERACTION TO THE ALPHA CHAIN OF FIBRINOGEN |
| Ariga T. |
- |
A ROLE OF SURFACE-BOUND PLASMINOGEN IN THE LIVER REGENERATION IN RAT |
| |
- |
A NOVEL FIBRINOLYTIC FACTOR ADIPOMIN REGULATES ADIPOSITY |
| Arikat M. |
- |
CHARACTERISATION OF THE MOLECULAR GENETIC DEFECTS UNDERLYING GLANZMANN'S THROMBASTHENIA IN JORDANIAN FAMILIES |
| Arinami T. |
- |
CLINICAL PROFILE AND MOLECULAR BASIS OF GLANZMANN'S THROMBASTHENIA [GT] IN THE SULTANATE OF OMAN |
| Arjmandi Rafsanjani K. |
- |
CLINICAL FEATURES AND TREATMENT OUTCOMES OF INFANTS WITH IMMUNE THROMBOCYTOPENIC PURPURA |
| Arkin C.F. |
- |
RESULT DISCREPANCIES BETWEEN TWO LUPUS ANTICOAGULANT (LA) METHODS |
| Armstrong A.E. |
- |
ACQUIRED HEMOPHILIA: ANALYSIS OF THE HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY (HTRS) REGISTRY |
| Armstrong E. |
- |
SIGNIFICANT DISTINCTION BETWEEN PLASMA- AND PLATELET-DEPENDENT COAGULATION ACTIVITY IN HEMOPHILIA A PATIENTS |
| Armstrong A. |
- |
EPIDEMIOLOGY OF THROMBOEMBOLISM (TE) IN CHILDREN WITH CANCER |
| Arnalsteen L. |
- |
ANTITHROMBIN REDUCES COAGULATION AND INFLAMMATION IN A PIG MODEL OF ISLET TRANSPLANTATION |
| Arnaud L. |
- |
IMMUNO-MAGNETIC ENRICHMENT FOLLOWED BY MULTI-PARAMETER FLOW CYTOMETRY: A NEW APPROACH TO COUNT CIRCULATING ENDOTHELIAL CELLS |
| Arnaud B. |
- |
MONOCYTES DOWN-REGULATE INITIAL PHASE OF COLLAGEN-INDUCED PLATELET ACTIVATION |
| Arndt B. |
- |
AN IN VIVO RISK/BENEFIT COMPARISON OF THE EFFECTS OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR WITH THROMBIN INHIBITORS, WARFARIN AND CLOPIDOGREL |
| Arnesen H. |
- |
ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PLASMA FROM PATIENTS WITH AMI DURING ANTITHROMBOTIC TREATMENT |
| |
- |
PLASMINOGEN ACTIVATOR INHIBITOR-1 ACTIVITY PREDICTS RHYTHM OUTCOME AFTER ELECTRICAL CARDIOVERSION FOR ATRIAL FIBRILLATION |
| |
- |
BENEFICIAL EFFECT OF 1-YEAR OPTIMAL MEDICAL TREATMENT, INDEPENDENT OF ADDITIONAL PTA, ON INFLAMMATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD) |
| Arning M. |
- |
ELTROMBOPAG, AN ORAL, NON-PEPTIDE PLATELET GROWTH FACTOR, INCREASES PLATELET COUNTS AND DECREASES BLEEDING IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA IN A PHASE III STUDY |
| Arnold E. |
- |
HIGH PREVALENCE OF IRON DEFICIENCY AMONG PATIENTS REFERRED FOR EVALUATION OF A BLEEDING DISORDER |
| |
- |
GLOBAL ASSAYS OF PLATELET FUNCTION IN DIAGNOSTIC TESTING |
| Arnott S. |
- |
USE OF RECOMBINANT ACTIVATED FACTOR VIIA (RFVIIA) IN MASSIVE HAEMORRHAGE |
| Arnould B. |
- |
MULTINATIONAL DEVELOPMENT OF A QUESTIONNAIRE ASSESSING PATIENT SATISFACTION WITH ANTI-COAGULANT TREATMENT |
| Arocas V. |
- |
PROTEASE NEXIN-1 AND THROMBOMODULIN FORM COMPLEXES WITH A HIGHLY POTENT ANTI-THROMBIN ACTIVITY |
| Aronis S. |
- |
MORE THAN ONE EPISODES IN CHILDHOOD ITP WITH A MEDIASTINUM OF MONTHS OR YEARS. A 30 YEARS RETROSPECTIVE ANALYSIS |
| Aronis-Vournas S. |
- |
DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS |
| Arpaia G. |
- |
D-DIMER AS PREDICTIVE FACTOR FOR VENOUS THROMBOEMBOLISM IN CANCER PATIENTS BEFORE CHEMOTHERAPY |
| Arpin M. |
- |
VASP PHOSPHORYLATION ANALYSIS PRIOR TO PERCUTANEOUS CORONARY INTERVENTION FOR EXCLUSION OF POST-PROCEDURAL MAJOR ADVERSE CARDIOVASCULAR EVENTS |
| Arquati M. |
- |
E-SELECTIN AND TFPI ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN STABLE CORONARY PATIENTS: THE BASELINE FINDINGS OF THE MIAMI STUDY |
| Arrabal S. |
- |
CONTRIBUTION OF CHROMATOGRAPHY STEPS IN PRION REMOVAL IN PLASMA-DERIVED PRODUCT MANUFACTURING |
| |
- |
EFFICIENT PRION REMOVAL DURING THE MANUFACTURING PROCESS OF BETAFACT, A HIGH-PURITY PLASMA DERIVED FACTOR IX |
| Arruda V.R. |
- |
SUCCESSFUL LONG TERM EXPRESSION OF FVIII AFTER GENE DELIVERY OF NOVEL ADENO-ASSOCIATED VIRAL VECTOR SEROTYPES IN HEMOPHILIA A DOGS |
| |
- |
IN VIVO EFFECTS OF MURINE AND HUMAN APC |
| |
- |
THE ROLE OF FACTOR VIII IN THE DEVELOPMENT OF ATHEROSCLEROTIC LESIONS IN MURINE MODELS |
| Arruda V. |
- |
PROTEASE-ACTIVATED RECEPTOR 2 (PAR-2) A NOVEL TARGET TO PREVENT FIX INHIBITOR FORMATION |
| Arruda V.R. |
- |
DUAL GENE TRANSFER OF FGF-2 AND PDGF-BB USING PLASMID DNA PROMOTES EFFECTIVE ANGIOGENESIS AND ARTERIOGENESIS IN A RODENT MODEL OF HINDLIMB ISCHEMIA |
| |
- |
NOVEL MODELS OF THROMBOPHILIA RESULT IN SPONTANEOUS PERIPHERAL THROMBOSIS AND PREGNANCY-RELATED COMPLICATIONS |
| Arsène S. |
- |
ASSOCIATION BETWEEN THE HOMOZYGOUS STATUS FOR THE 807T ALLELE OF ITGA2 AND RETINAL ARTERY OCCLUSION |
| Arslan N. |
- |
USAGE OF FACTOR VIIA IN A CASE OF HEMORRHAGIC CYSTITIS DEVELOPED SECONDARY TO CHEMOTHERAPY |
| Arthur J.F. |
- |
RAPID LIGAND-INDUCED DIMERIZATION OF PLATELET GLYCOPROTEIN VI |
| Artoni A. |
- |
GENETIC CHARACTERIZATION OF PATIENTS WITH BERNARD-SOULIER SYNDROME AND THEIR RELATIVES FROM SOUTHERN IRAN |
| |
- |
PHENOTYPIC ANALYSIS OF THREE MUTATIONS CAUSING GLANZMANN THROMBASTHENIA |
| Arveiler B. |
- |
PLATELET ABNORMALITIES IN PATIENTS WITH CONSTITUTIONAL DEFECTS IN FILAMIN A |
| Arya R. |
- |
VENOUS THROMBOSIS (VTE) HAS AN ADVERSE IMPACT ON THE SURVIVAL IN PATIENTS WITH MALIGNANCY |
| |
- |
USE OF RECOMBINANT ACTIVATED FACTOR VIIA (RFVIIA) IN MASSIVE HAEMORRHAGE |
| Aryuchai K. |
- |
FIBRINOGEN THR312ALA BUT NOT FXIIIA VAL34LEU AND FXIIIB HIS95ARG POLYMORPHISMS ASSOCIATED WITH THAI DEEP VENOUS THROMBOSIS |
| Aryurachai K. |
- |
NORMALIZED PHOSPHATIDYLSERINE EXPRESSION ON RED BLOOD CELLS IN CHILDREN WITH SEVERE THALASSEMIA DISEASE AFTER STEM CELL TRANSPLANTATION |
| Arza B. |
- |
PERFORMANCE OF A NEW TURBIDIMETRIC D-DIMER ASSAY ADAPTED TO AUTOMATED COAGULOMETERS |
| Arzanian M. |
- |
CHILDHOOD GERM CELL TUMOR PRECEDING BY CHRONIC LONGSTANDING DIC |
| Asada Y. |
- |
PLATELET IS AN IMPORTANT FACTOR IN VENOUS THROMBOEMBOLISM: INTERACTION OF VON WILLEBRAND FACTOR AND PLATELET GPIB PROMOTES VENOUS THROMBUS GROWTH |
| |
- |
MECHANISMS OF THROMBUS FORMATION DIFFER BETWEEN ATHEROSCLEROTIC AND NORMAL ARTERIES IN HYPERCHOLESTEROLEMIC RABBITS |
| |
- |
FUNCTIONAL REGULATION OF VON WILLEBRAND FACTOR ON THE FORMATION OF PLATELET THROMBI UNDER BLOOD FLOW CONDITION BY ITS SPECIFIC CLEAVING PROTEASE OF ADAMTS13 |
| |
- |
ADAMTS-13 WITHIN THROMBUS DOWN-REGULATES THROMBUS FORMATION UNDER FLOW CONDITIONS |
| Asadollahi S. |
- |
THE CLINICAL RESULTS OF P32 RADIOSYNOVECTOMY IN HEMOPHILIC PATIENTS WITH CHRONIC SYNOVITIS |
| Asai F. |
- |
FLOW CYTOMETRIC ANALYSIS OF VASP PHOSPHORYLATION IN PLATELETS TREATED WITH THE ACTIVE METABOLITE OF PRASUGREL, A P2Y12 ADP RECEPTOR ANTAGONIST |
| |
- |
COMPARISON OF ANTIPLATELET AND ANTITHROMBOTIC EFFECTS OF PRASUGREL AND AZD6140 |
| Asakura H. |
- |
PATHOPHYSIOLOGICAL MECHANISMS OF VASCULOPATHY IN SYSTEMIC SCLERODERMA (SSC): PLATELET ACTIVATION INDUCED BY APL IS ASSOCIATED WITH ARTERIAL THROMBOSES AND DIGITAL PITTING SCAR IN SSC PATIENTS |
| |
- |
CLINICAL SIGNIFICANCE OF PLATELET-DERIVED MICROPARTICLE (PDMP) IN APS: PLASMA LEVELS OF PDMP WERE SIGNIFICANTLY ELEVATED IN APS PATIENTS WITH ARTERIAL THROMBOSES |
| Asanuma K. |
- |
REGULATION OF BREAST CANCER CELL GROWTH, METASTASIS AND ANGIOGENESIS BY PROTEIN C INHIBITOR |
| Asbel N.R. |
- |
A PHASE II DOUBLE-BLIND PLACEBO-CONTROLLED PARALLEL-GROUP RANDOMIZED STUDY OF EXTENDED PROPHYLAXIS WITH ODIPARCIL FOLLOWING TOTAL HIP ARTHROPLASTY (THA) |
| Ascani A. |
- |
SOCIAL COSTS OF ANTICOAGULANT TREATMENT FOR ATRIAL FIBRILLATION |
| Asencio J. |
- |
ANKLE REPLACEMENT IN SEVERE BLEEDING DISORDERS: RETROSPECTIVE STUDY ON 17 CASES |
| Ashby D. |
- |
LACK OF EFFECT OF INFLUENZA IMMUNISATION ON ANTICOAGULANT CONTROL IN PATIENTS ON LONG-TERM WARFARIN |
| Asher I. |
- |
THROMBOPHILIA IS ASSOCIATED WITH HEPARIN THROMBOPROPHYLAXIS FAILURE IN PATIENTS WITH ACUTE TRAUMATIC SPINAL CORD INJURY |
| Ashman L.K. |
- |
IMPAIRED 'OUTSIDE-IN' INTEGRIN ALPHAIIBBETA3 SIGNALING AND THROMBUS STABILITY IN CD151 AND TSSC6-DEFICIENT MICE |
| Ashouri E. |
- |
GENETIC CHARACTERIZATION OF PATIENTS WITH BERNARD-SOULIER SYNDROME AND THEIR RELATIVES FROM SOUTHERN IRAN |
| Ashrani A.A. |
- |
IMPACT OF VENOUS THROMBOEMBOLISM, VENOUS STASIS SYNDROME, VENOUS OUTFLOW OBSTRUCTION AND VENOUS VALVULAR INCOMPETENCE ON QUALITY OF LIFE AND ACTIVITIES OF DAILY LIVING: A POPULATION-BASED CASE-CONTROL STUDY |
| |
- |
RISK FACTORS FOR VENOUS THROMBOEMBOLISM (VTE) AMONG ACTIVE CANCER PATIENTS: A POPULATION-BASED CASE-CONTROL STUDY |
| Asmelash G. |
- |
THE TYPE OF MANIFESTATION OF THE ANTIPHOSPHOLIPID SYNDROME IN RELATION TO THE AGE OF THE PATIENTS |
| Asmis L.M. |
- |
COMPARISON OF THREE METHODOLOGIES TO ASSAY D-DIMER LEVELS IN SURGICAL PATIENTS: D DIMER ON MINIVIDAS VS. TINA-QUANT ON MODULAR P VS. TINA-QUANT ON BEHRING COAGULATION SYSTEM - A CALL FOR STANDARDISATION IN D-DIMER TESTING |
| Asmis L. |
- |
DISTINCTIVE THROMBOELASTOGRAPHIC FINDINGS (TEG-PM IN RESPONSE TO ADP) IN A FAMILY WITH BERNARD SOULIER SYNDROME |
| Aspelin T. |
- |
CARDIAC tPA RELEASE DURING SYMPATHETIC NERVE STIMULATION IN PIGS DECREASES BY REPEATED STIMULATIONS |
| Asproudis I. |
- |
A HIGH NORMAL VALUE OF PLASMA PROTEIN Z IS AN UNCOMMON FINDING IN NON-ARTERITIC ISCHEMIC OPTIC NEUROPATHY (N-AION) PATIENTS |
| Assadian A. |
- |
LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS |
| Assanelli D. |
- |
TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION |
| Asselta R. |
- |
DATABASE ON RARE BLEEDING DISORDER (RBDS): PHENOTYPE AND GENOTYPE ANALYSIS ON 400 AFFECTED PATIENTS |
| |
- |
MISSENSE MUTATIONS IN THE COILED-COIL REGION OF FIBRINOGEN AALPHA CHAIN CAUSE FIBRINOGEN DEFICIENCY BY IMPAIRING DIMERIZATION OF TRIMERIC INTERMEDIATES |
| |
- |
CHARACTERIZATION OF THE F11 ALTERNATIVE SPLICING PATTERN: IDENTIFICATION OF A NOVEL COAGULATION FXI ISOFORM |
| |
- |
A NOVEL MECHANISM FOR CONGENITAL AFIBRINOGENEMIA BASED ON PSEUDOEXON ACTIVATION IN THE FIBRINOGEN GAMMA-CHAIN GENE |
| |
- |
SIMULTANEOUS GENOTYPING OF FXI TYPE II AND TYPE III MUTATIONS BY MULTIPLEX REAL-TIME PCR IN HEALTHY ITALIANS AND IN FXI-DEFICIENT PATIENTS |
| |
- |
ALTERNATIVE SPLICING AND NONSENSE-MEDIATED DECAY IN THE F5 GENE |
| Assunção E. |
- |
FACTOR V INHIBITORS: DIVERSITY IN CLINICAL PRESENTATION |
| Aster R.H. |
- |
RARE ANTIGENS IN NEONATAL ALLOIMMUNE THROMBOCYTOPENIA |
| |
- |
MONOCLONAL ANTIBODIES THAT MIMIC ANTIBODIES FOUND IN PATIENTS WITH DRUG (QUININE(QN))-INDUCED IMMUNE THROMBOCYTOPENIA (DITP): IMPLICATIONS FOR THE PATHOGENESIS OF DITP |
| Aster R. |
- |
HUMAN PLATELETS CIRCULATING IN MICE: APPLICATIONS FOR INTERROGATING PLATELET FUNCTION AND SURVIVAL, THE EFFICACY OF ANTI-PLATELET THERAPEUTICS, AND THE MOLECULAR BASIS OF PLATELET IMMUNOLOGICAL DISORDERS |
| Astermark J. |
- |
THE CAPACITY TO GENERATE THROMBIN IN FACTOR VIII INHIBITOR PLASMAS DIFFERS AMONG COMMERCIAL CONCENTRATES AND IS ASSOCIATED WITH VON WILLEBRAND FACTOR CONTENT. IS THIS OF IMPORTANCE FOR ITI SUCCESS? |
| |
- |
GENETIC AND ENVIRONMENTAL RISK FACTORS FOR FVIII INHIBITOR DEVELOPMENT |
| |
- |
BLEEDING PATTERNS ON PROPHYLAXIS FOR SEVERE HAEMOPHILIA: WEEK DAY AND SEASONAL INFLUENCE |
| |
- |
BREAKTHROUGH BLEEDING IN SEVERE HAEMOPHILIA A. DOES THE FVIII TROUGH LEVEL MATTER? |
| Asti D. |
- |
INTERFERENCE OF FACTOR V LEIDEN ON PROTEIN S ACTIVITY. EVALUATION OF A NEW PROTHROMBIN TIME-BASED ASSAY |
| Ataiei Z. |
- |
THE PROTECTIVE EFFECT OF FXIII VAL34LEU POLYMORPHISM AGAINST VENOUS THROMBOSIS IN IRANIAN PATIENTS |
| Atallah A. |
- |
EFFECT OF THE IMPLEMENTATION OF A VENOUS THROMBOEMBOLISM PROPHYLAXIS GUIDELINE IN THE MANAGEMENT OF SURGICAL AND ORTHOPEDIC PATIENTS IN A PRIVATE TERTIARY HOSPITAL |
| Atamonov V.A. |
- |
D-DIMER IN PATIENTS WITH ACUTE LEUKEMIA AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS |
| Ataullakhanov F. |
- |
WALL CLOT GROWTH IN PLASMA: EFFECT OF HIGH DOSES RECOMBINANT FVIIA |
| Ataullakhanov F.I. |
- |
THRESHOLD BEHAVIOR OF THE BLOOD CLOTTING SYSTEM ACTIVATED BY THE TISSUE FACTOR |
| |
- |
BLOOD FLOW SUPPRESSES FEEDBACK ACTIVATION OF EXTRINSIC TENASE BY FACTOR XA AND PREVENTS CLOTTING |
| |
- |
FORMATION OF SUBPOPULATIONS WITH DIFFERENT PHOSPHATIDYLSERINE EXPRESSION DURING THROMBIN-STIMULATED PLATELET ACTIVATION IS CONTROLLED BY ALPHA-GRANULE ADP SECRETION |
| Athale U. |
- |
EPIDEMIOLOGY OF THROMBOEMBOLISM (TE) IN CHILDREN WITH CANCER |
| Athanasiou M. |
- |
HAEMOSTATIC PROFILE OF FULL TERM HEALTHY SMALL FOR GESTATIONAL AGE (SGA) NEONATES |
| Athanassiadou F. |
- |
HAEMOSTATIC PROFILE OF FULL TERM HEALTHY SMALL FOR GESTATIONAL AGE (SGA) NEONATES |
| Atkinson B.T. |
- |
INACTIVE TISSUE FACTOR CONTAINING EXPOSED THIOLS RESIDES ON THE SURFACE OF UNSTIMULATED ENDOTHELIAL CELLS |
| Atsumi T. |
- |
THE P38 MITOGEN-ACTIVATE PROTEIN KINASE MAPK) PATHWAY MEDIATES THE INDUCTION OF TISSUE FACTOR EXPRESSION BY PHOSPHATIDYLSERINE-DEPENDENT ANTIPROTHROMBIN ANTIBODIES WITH LUPUS ANTICOAGULANT ACTIVITY |
| |
- |
DIAGNOSTIC SIGNIFICANCE OF TESTING ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FOR THE ANTIPHOSPHOLIPID SYNDROME |
| Atsumi G. |
- |
CIRCADIAN VARIATIONS IN COAGULATION AND FIBRINOLYTIC FACTORS AMONG FOUR STRAINS OF MICE |
| Atta N. |
- |
RISK FACTORS AND OUTCOME OF THROMBOEMBOLIC EVENTS IN CHILDREN UNDERGOING CARDIAC SURGERY |
| Attanasio M. |
- |
QUALITY OF OAT AND VTE RECURRENCE |
| |
- |
MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME |
| |
- |
PLATELET FUNCTION EVALUATION BY USING A NEW POINT-OF-CARE SYSTEM AND PLATELET LIGHT-TRANSMISSION AGGREGATION IN A LARGE COHORT OF CORONARY ARTERY DISEASE PATIENTS |
| |
- |
GENETIC ANALYSIS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS-GAMMA (PPARG) PROMOTERS: ACUTE CORONARY SYNDROME PATIENTS VERSUS CONTROLS |
| |
- |
HOMOCYSTINURIA AND CARDIOVASCULAR MANIFESTATIONS: 5 ITALIAN CASES |
| Attema M.E. |
- |
PERIOPERATIVE PROPHYLACTIC DOSING OF TINZAPARIN IN MORBID OBESE PATIENTS |
| Atwal H. |
- |
PEGYLATION PROTECTS FACTOR VIII FROM THE INHIBITION OF ANTIBODY INHIBITORS |
| Aubry M.L. |
- |
SEVERE FACTOR VII DEFICIENCY DUE TO MUTATIONS IN THE FACTOR VII GENE PROMOTER |
| Auerswald G. |
- |
THE CHALLENGE OF PRAEOPERATIVE INVESTIGATION OF HEREDITARY AND ACQUIRED COAGULATION DISORDERS IN CHILDREN AND ADOLESCENTS |
| |
- |
EFFICACY AND SAFETY OF A HIGHLY PURIFIED FACTOR IX CONCENTRATE IN PAEDIATRIC PATIENTS WITH HAEMOPHILIA B - RESULTS OF A CLINICAL TRIAL AND A POST MARKETING SURVEILLANCE STUDY |
| |
- |
INHIBITOR OF FVII IN CONGENITAL SEVERE FACTOR VII DEFICIENCY |
| |
- |
GYNAECOLOGICAL BLEEDING IN CONGENITAL FACTOR VII DEFICIENCY |
| |
- |
PHYSICAL EXAMINATION IN PATIENTS WITH SEVERE HEMOPHILIA UNDER PROPHYLACTIC TREATMENT - EFFICACY OF AN EARLY LONG-TERM PROPHYLAXIS? |
| |
- |
PROSPECTIVE POST LICENSURE SURVEILLANCE OF EFFICACY AND TOLERABILITY OF A HIGH PURITY, DOUBLE VIRUS INACTIVATED VWF/FVIII CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND'S DISEASE |
| |
- |
CLINICAL EFFICACY AND SAFETY OF A NOVEL HIGH-PURITY, DOUBLE VIRUS-INACTIVATED VWF/FVIII-CONCENTRATE IN THE TREATMENT OF VON WILLEBRAND DISEASE AN UPDATE ON THE CLINICAL PROGRAMME |
| Auger J.M. |
- |
A GADS-INDEPENDENT PATHWAY OF PLCGAMMA2 REGULATION DOWNSTREAM OF THE COLLAGEN RECEPTOR, GPVI |
| |
- |
CONTRIBUTIONS OF COLLAGEN AND GLYCOPROTEIN VI SIGNALLING IN THE INTRINSIC PATHWAY OF COAGULATION |
| |
- |
DYNAMIC SIGNALLING EVENTS AND FIBRIN-INDEPENDENT RETRACTION CONTRIBUTE TO THROMBUS STABILITY UNDER SHEAR |
| |
- |
COLLAGEN PROMOTES SUSTAINED GPVI SIGNALING IN PLATELETS AND CELL LINES |
| Aujesky D. |
- |
MULTI-DETECTOR SPIRAL COMPUTED TOMOGRAPHY ALONE VERSUS COMBINED WITH LOWER LIMB COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF PULMONARY EMBOLISM: A RANDOMISED NON-INFERIORITY TRIAL |
| Aukrust P. |
- |
ELEVATED SERUM LEVELS OF LIGHT IN PULMONARY ARTERIAL HYPERTENSION-POTENTIAL INVOLVEMENT IN THROMBUS FORMATION |
| Aumont M. |
- |
D-DIMER AND PROGNOSIS IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION |
| Austin S.K. |
- |
DECREASED ADAMTS13 AND ANTI-ADAMTS13 IN THE ANTIPHOSPHOLIPID SYNDROME (APS) |
| |
- |
SUCCESSFUL MANAGEMENT OF LATE OBSTETRIC COMPLICATIONS IN THE ANTIPHOSPHOLIPID SYNDROME |
| Austin S. |
- |
COMBINING 4T'S PRE-TEST CLINICAL SCORE AND ID-PAGIA HEPARIN/PF4 TEST TO EXCLUDE HEPARIN INDUCED THROMBOCYTOPENIA (HIT) |
| Austin H. |
- |
THE ALPHA FIBRINOGEN THR312ALA POLYMORPHISM AND VENOUS THROMBOEMBOLISM IN AMERICAN CAUCASIANS AND AFRICAN AMERICANS: THE GATE STUDY |
| |
- |
POLYMORPHISMS IN THE 3'-END OF THE FIBRINOGEN GAMMA GENE AND RISK OF VENOUS THROMBOEMBOLISM IN THE AFRICAN-AMERICAN AND CAUCASIAN POPULATION |
| Austin S.K. |
- |
MANAGING PERI-DELIVERY ANTICOAGULATION IN WOMEN ON THERAPEUTIC DOSE LOW-MOLECULAR WEIGHT HEPARIN: A ROLE FOR UNFRACTIONATED HEPARIN |
| Austin H. |
- |
PULMONARY EMBOLISM, OBESITY, DIABETES, AND HYPERTENSION AMONG AMERICAN CAUCASIANS IN THE GATE STUDY |
| |
- |
VENOUS THROMBOEMBOLISM, FACTOR V LEIDEN, AND PROTHROMBIN 20210 AMONG AMERICAN CAUCASIANS IN THE GATE STUDY |
| Auteri A. |
- |
INFLUENCE OF LECTIN-LIKE OX-LDL RECEPTOR-1 (LOX-1) AND NITRIC OXIDE SINTHASE (NOS) POLYMORPHISMS IN ATORVASTATIN ANTITHROMBOTIC ACTION AND CARDIOVASCULAR EVENTS RATE |
| Authi K.S. |
- |
AKT ACTIVATION BY PHOSPHAPHATIDYLINOSITOL-3,4,5-TRISPHOSPHATE IN HUMAN PLATELETS IS DEPENDENT ON EXTRACELLULAR CA2+ |
| Auton M. |
- |
STRUCTURAL AND THERMODYNAMIC EFFECTS OF TYPE 2M AND TYPE 2B VWD MUTATIONS IN THE A1 DOMAIN OF VWF |
| Avery M. |
- |
EPOTHILONE B INHIBITS NEOINTIMAL FORMATION AFTER RAT CAROTID INJURY THROUGH THE REGULATION OF CELL CYCLE-RELATED PROTEINS |
| Avigliano L. |
- |
MODULATION OF PLATELET FUNCTION BY THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL |
| Avilov O.E. |
- |
BLOOD FLOW SUPPRESSES FEEDBACK ACTIVATION OF EXTRINSIC TENASE BY FACTOR XA AND PREVENTS CLOTTING |
| Awidi A.A. |
- |
CHARACTERISATION OF THE MOLECULAR GENETIC DEFECTS UNDERLYING GLANZMANN'S THROMBASTHENIA IN JORDANIAN FAMILIES |
| Awosile F.S. |
- |
DEFINING THE STRUCTURE OF MEMBRANE-BOUND HUMAN BLOOD COAGULATION FACTOR VA |
| Ay C. |
- |
ANGIOTENSIN-CONVERTING ENZYME (ACE) INSERTION/DELETION (I/D) POLYMORPHISM AND SERUM LEVELS OF ACE IN VENOUS THROMBOEMBOLISM (VTE) |
| |
- |
P-SELECTIN (P-SEL) GENE HAPLOTYPES MODULATE SOLUBLE (S) P-SEL LEVELS AND INCREASE THE RISK OF VENOUS THROMBOEMBOLISM (VTE) |
| |
- |
A HIGH PLATELET COUNT INDEPENDENTLY PREDICTS VENOUS THROMBOEMBOLISM IN CANCER PATIENTS |
| |
- |
SOLUBLE P-SELECTIN AND THE RISK OF THROMBOTIC EVENTS IN PATIENTS WITH A LUPUS ANTICOAGULANT IN A PROSPECTIVE COHORT STUDY |
| Ayata M. |
- |
INCIDENCE OF PULMONARY THROMBOEMBOLISM IN AUTOPSY CASES IN A JAPANESE GENERAL HOSPITAL |
| Aydogan G. |
- |
FX DEFICIENCY: CHARACTERISTICS AND TREATMENT OUTCOME OF SEVEN CASES |
| |
- |
EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA |
| |
- |
THE RESULTS OF OUR FEBRILE NEUTROPENIA MANAGEMENT REPORTS FOR THREE YEARS |
| |
- |
RADIOSYNOVECTOMY WITH YTRIUM-90 AND RHENIUM-186 IN HEMOPHILIC ARTHROPATY |
| Aydogdu S. |
- |
RADIOISOTOPE SYNOVECTOMY WITH RHENIUM 186 FOR TREATMENT OF HEMOPHILIC SYNOVITIS |
| Aygören-Pürsün E. |
- |
IGE SPECIFIC FOR HUMAN FVIII FROM A PATIENT WITH HEMOPHILIA A BINDS TO THE C2 DOMAIN AND INHIBITS FVIII FUNCTION |
| Aykan S. |
- |
ACTIVATED PROTEIN C ATTENUATES LIPOPOLYSACCHARIDE-INDUCED ACTIVATION OF CELL DEATH AND TUMOUR NECROSIS FACTOR-ALPHA PRODUCTION IN MURINE MICROGIAL CELLS |
| Ayob Y. |
- |
IS TODAY'S THROMBOPHILIA PROFILE ADEQUATE IN IDENTIFYING A POSSIBLE CAUSE FOR RECURRENT FETAL LOSS IN WOMEN? |
| |
- |
ACQUIRED VON WILLEBRAND DISEASE IN A PATIENT WITH SYSTEMIC LUPUE ERYTHEMATOSUS |
| Ayprasert N. |
- |
INTRACRANIAL AND SPINAL HEMORRHAGE IN ADULT HEMOPHILIA A IN SIRIRAJ HOSPITAL, THAILAND |
| Aytac S. |
- |
RISK FACTORS AND OUTCOME OF PEDIATRIC THROMBOTIC EPISODES IN A SINGLE CENTER |
| Ayuso M.S. |
- |
INTEGRIN-LINKED KINASE (ILK) IN PLATELET ALPHAIIB-BETA3 SIGNALING AND ARTERIAL THROMBOSIS |
| Azarafrooz F. |
- |
RELATIVE ANTICOAGULANT AND ANTITHROMBOTIC EFFECTS OF HEPARIN AND LOW MOLECULAR WEIGHT HEPARINS IN HUMAN AND FELINE BLOOD PLASMA. POTENTIAL THERAPEUTIC IMPLICATIONS |
| Azari B.M. |
- |
THE F11 RECEPTOR (F11R, JAM-A) IN ATHEROTHROMBOSIS: OVEREXPRESSION OF F11R IN ATHEROSCLEROTIC PLAQUES |
| Azarkeivan A. |
- |
THROMBOTIC EVENTS IN PATIENTS WITH ELEVATED FVIII LEVEL |
| Azarkeyvan A. |
- |
HIGH PREVALENCE OF ELEVATED FACTOR VIII IN IRANIAN PATIENT WITH IDIOPATHIC VENOUS THROMBOEMBOLISM |
| Azarm T. |
- |
HELICOBACTER PYLORI ERADICATION CAN INDUCE PLATELET RECOVERY IN CHRONIC REFRACTORY IDIOPATHIC THROMBOCYTOPENIC PURPURA |
| Azarova O.Y. |
- |
GENETIC POLYMORPHISM R353Q OF FACTOR VII HAS PROTECTIVE EFFECT IN THREATENED MISCARRIAGE |
| Azizi M. |
- |
THE ABCB1 (MDR1) C3435T POLYMORPHISM DOES NOT INFLUENCE PHARMACODYNAMIC RESPONSE TO CLOPIDOGREL IN HEALTHY SUBJECTS |
| |
- |
LACK OF ENDOTHELIAL DYSFUNCTION IN THROMBOANGIITIS OBLITERANS |
| Aznar J. |
- |
ATS-13 ACTIVITY AS A COMMON MARKER OF THE ENDOTHELIAL DYSFUNCTION DEVELOPING IN THROMBOTIC MICROANGIOPATHIES OF DIFFERENT ORIGIN |
| |
- |
IDENTIFICATION OF DELETIONS IN WOMEN WITH FAMILY ANTECEDENTS OF SEVERE HAEMOPHILIA B BY MULTIPLE LIGATION PROBE AMPLIFICATION METHOD. COMPARISON WITH QUANTITATIVE REAL-TIME ASSAY |
| |
- |
CLINICAL, GENETIC, FUNCTIONAL AND CONFORMATIONAL HETEROGENEITY OF CONGENITAL ANTITHROMBIN DEFICIENCY. RESULTS FROM 27 UNRELATED CASES |
| Aznar J.A. |
- |
INFLUENCE OF ADDING 4% BSA IN THE BETHESDA ASSAY FOR FACTOR VIII INHIBITOR QUANTIFICATION |
| Azzaro M. |
- |
PLASMA COAGULATION TESTS AND GENETIC THROMBOPHILIC MUTATION STUDIES ARE MANDATORY FOR PREVENTING THE IDIOPATHIC RECURRENT ABORTIONS OR REPEATED FETAL LOSS IN HEALTHY WOMEN |
| |
- |
THE THERAPEUTICAL STRATEGIES ARE EFFECTIVE TO PREVENT THE RECURRENT ABORTIONS, REPEATED FETAL LOSS OR THE INTRAUTERINE FETAL GROWTH RETARDATION IN WOMEN WITH COAGULATION ABNORMALITIES AND/OR GENETIC THROMBOPHILIC MUTATIONS |
